Presentations
List of all online presentations previously presented at VHPB meetings
| Correlation Network | ||
| Eberhard Schatz | ||
| Mar/2016 – Ljubljana, Slovenia | 2.1 Mb (.pdf) | |
| Health Without Barriers (HWBs) – How screening and testing of prisoners can be improved: an European example from Health Without Barriers (HWBs) – The European Federation for Prison Health | ||
| Sergio Babudieri | ||
| Mar/2016 – Ljubljana, Slovenia | 841 Kb (.pdf) | |
| EMCDDA European Monitoring Centre for Drugs and Drug Addiction + a systematic review of prevalence and cost-effectiveness of screening hepatitis B and C in Europe | ||
| Lucas Wiessing | ||
| Mar/2016 – Ljubljana, Slovenia | 1.5 Mb (.pdf) | |
| Organisation and funding of the health care system in Lithuania | ||
| Laimuté Vaideliené | ||
| Nov/2015 – Riga, Latvia | 5.2 Mb (.pdf) | |
| National immunization program in Estonia | ||
| Irina Filippova | ||
| Nov/2015 – Riga, Latvia | 2.1 Mb (.pdf) | |
| National immunization program in Latvia | ||
| Jurijs Perevoscikovs | ||
| Nov/2015 – Riga, Latvia | 1.1 Mb (.pdf) | |
| National program (Plan) for viral hepatitis control and treatment in Latvia | ||
| Jana Feldmane | ||
| Nov/2015 – Riga, Latvia | 783 Kb (.pdf) | |
| HAV, HBV, and HCV surveillance systems and results: Estonia | ||
| Jevgenia Epštein | ||
| Nov/2015 – Riga, Latvia | 461 Kb (.pdf) | |
| HAV, HBV, and HCV surveillance systems and results: Latvia | ||
| Raina Nikiforova | ||
| Nov/2015 – Riga, Latvia | 2.9 Mb (.pdf) | |
| HAV, HBV, and HCV surveillance systems and results: Lithuania | ||
| Saulius Caplinskas and Irma Caplinskiene | ||
| Nov/2015 – Riga, Latvia | 4.9 Mb (.pdf) | |
| HAV, HBV, and HCV surveillance systems and results: Estonia | ||
| Kristi Rüütel | ||
| Nov/2015 – Riga, Latvia | 1.1 Mb (.pdf) | |
| Epidemiology of different hepatides (B, C ) in Estonia | ||
| Kristi Huik | ||
| Nov/2015 – Riga, Latvia | 7.4 Mb (.pdf) | |
| Epidemiology of different hepatides (B, C ) in Latvia | ||
| Raina Nikiforova | ||
| Nov/2015 – Riga, Latvia | 2 Mb (.pdf) | |
| Epidemiology of different hepatides (B, C ) in Lithuania | ||
| Saulius Caplinskas and Irma Caplinskiene | ||
| Nov/2015 – Riga, Latvia | 3.6 Mb (.pdf) | |
| Lithuania: Hepatitis screening in the Lithuanian blood establishments | ||
| Joana Bikulčienė | ||
| Nov/2015 – Riga, Latvia | 1.5 Mb (.pdf) | |
| Estonia: People who injecting drugs | ||
| Aljona Kurbatova | ||
| Nov/2015 – Riga, Latvia | 115 Kb (.pdf) | |
| Latvia: Hepatitis prevention in the context of HIV prevention point work | ||
| Liva Gramatina | ||
| Nov/2015 – Riga, Latvia | 7.4 Mb (.pdf) | |
| Estonia: Hepatitis E virus in domestic pigs, wild boars, pig farm workers and hunters in Estonia | ||
| Tatiana Kuznetsova | ||
| Nov/2015 – Riga, Latvia | 3.7 Mb (.pdf) | |
| Molecular genetic characterization of hepatitis epidemiology in Latvia | ||
| Irina Sominskaya | ||
| Nov/2015 – Riga, Latvia | 1.9 Mb (.pdf) | |
| Molecular genetic characterization of hepatitis epidemiology in Lithuania | ||
| Valentina Liakina | ||
| Nov/2015 – Riga, Latvia | 971 Kb (.pdf) | |
| Control of hepatitis A- outbreak control in Latvia | ||
| Rita Korotinska | ||
| Nov/2015 – Riga, Latvia | 4.6 Mb (.pdf) | |
| NGO involved in creating awareness for viral hepatitis: Latvia | ||
| Kristaps Kaugurs | ||
| Nov/2015 – Riga, Latvia | 18.4Mb (.pdf) | |
| Global, regional and national strategic planning for viral hepatitis prevention and control | ||
| Antons Mozalevskis | ||
| Nov/2015 – Riga, Latvia | 783Kb (.pdf) | |
| European Vaccine Aciton Plan Goal 3: control of hepatitis B. Regional targets and priority activities | ||
| Liudmila Mosina | ||
| Nov/2015 – Riga, Latvia | 1.8Mb (.pdf) | |
| Lithuania: Treatment policies and access of treatment for chronic heptatis B and C | ||
| Ligita Jancoriene | ||
| Nov/2015 – Riga, Latvia | 3.9Mb (.pdf) | |
| Presentation of the VHPB meeting conclusions | ||
| David FitzSimons | ||
| Nov/2015 – Riga, Latvia | 104 Kb (.pdf) | |
| WHO: WHO Global Hepatitis Strategy: Moving toward elimination of hepatitis B and C | ||
| Stefan Wiktor | ||
| Jun/2015 – London, UK | 925 Kb (.pdf) | |
| WHO Euro: WHO-EURO: European regional goals for hepatitis B and C elimination | ||
| Antons Mozalevskis | ||
| Jun/2015 – London, UK | 406 Kb (.pdf) | |
| WHO Euro: Regional plan on Hepatitis B control | ||
| Liudmila Mosina | ||
| Jun/2015 – London, UK | 30Kb (.pdf) | |
| WHO | ||
| Stefan Wiktor | ||
| Jun/2015 – London, UK | 149Kb (.pdf) | |
| WHO EURO | ||
| Antons Mozalevskis | ||
| Jun/2015 – London, UK | 330Kb (.pdf) | |
| ECDC | ||
| Erika Duffell | ||
| Jun/2015 – London, UK | 509 Kb (.pdf) | |
| ELPA | ||
| Margaret Walker | ||
| Jun/2015 – London, UK | 3.7 Mb (.pdf) | |
| Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable | ||
| Deuffic-Burban Sylvie | ||
| Jun/2015 – London, UK | 729 Kb (.pdf) | |
| The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus | ||
| David Rein | ||
| Jun/2015 – London, UK | 579 Kb (.pdf) | |
| Burden of hepatitis C in Europe- The Case of France and Romania | ||
| Gustaf Ortsäter | ||
| Jun/2015 – London, UK | 865 Kb (.pdf) | |
| Georgia | ||
| Maia Tsereteli | ||
| Jun/2015 – London, UK | 276 Kb (.pdf) | |
| Greece | ||
| Angelos Hatzakis | ||
| Jun/2015 – London, UK | 670 Kb (.pdf) | |
| Belgium | ||
| Yves Horsmans | ||
| Jun/2015 – London, UK | 901 Kb (.pdf) | |
| Bulgaria | ||
| Stanimir Hasurdjiev | ||
| Jun/2015 – London, UK | 139 Kb (.pdf) | |
| Romania | ||
| Odette Popovici | ||
| Jun/2015 – London, UK | 763 Kb (.pdf) | |
| New WHO report : Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research | ||
| Panos Kanavos | ||
| Jun/2015 – London, UK | 435 Kb (.pdf) | |
| Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness? | ||
| Livio Garattini | ||
| Jun/2015 – London, UK | 1.4 Mb (.pdf) | |
| New treatments for hepatitis C: strategies for achieving universal access | ||
| Céline Grillon | ||
| Jun/2015 – London, UK | 1.1 Mb (.pdf) | |
| GAVI | ||
| Mark Kane | ||
| Jun/2015 – London, UK | 175 Kb (.pdf) | |
| Available Hepatitis Information: how can this be used to convince decision makers and potential funders. Example of available information | ||
| Homie Razavi | ||
| Jun/2015 – London, UK | 739 Kb (.pdf) | |
| Conclusions of the meeting | ||
| David FitzSimons | ||
| Jun/2015 – London, UK | 46 Kb (.pdf) | |
| 22 years achievements and impact of VHPB | ||
| Johannes Hallauer – Mark Kane | ||
| Nov/2014 – Antwerp, Belgium | 2.2 Mb (.pdf) | |
| Patients perspective | ||
| Johannes Hallauer – Mark Kane | ||
| Nov/2014 – Antwerp, Belgium | 485 Kb (.pdf) | |
| Perspective of Viral Hepatitis Control | ||
| Nedret Emirogly | ||
| Nov/2014 – Antwerp, Belgium | 466 Kb (.pdf) | |
| Perspective of Viral Hepatitis Control | ||
| Nedret Emirogly | ||
| Nov/2014 – Antwerp, Belgium | 466 Kb (.pdf) | |
| Global Overview of Viral Hepatitis | ||
| Stefan Wiktor | ||
| Nov/2014 – Antwerp, Belgium | 2.1 Mb (.pdf) | |
| Overview of current hepatitis prevention and control issues | ||
| John Ward | ||
| Nov/2014 – Antwerp, Belgium | 3.1Mb (.pdf) | |
| Prevention and control of viral hepatitis B and C in WHO European Region | ||
| Nedret Emiroglu | ||
| Nov/2014 – Antwerp, Belgium | 700Kb (.pdf) | |
| Vaccination policies and coverage in EU – WHO Euro | ||
| Liudmila Mosina | ||
| Nov/2014 – Antwerp, Belgium | 430Kb (.pdf) | |
| Italy (2002) | ||
| Alessandro Zanetti | ||
| Nov/2014 – Antwerp, Belgium | 812 Kb (.pdf) | |
| Portugal (2010) | ||
| Rui Tato Marinho | ||
| Nov/2014 – Antwerp, Belgium | 10Mb (.pdf) | |
| Greece (2007) | ||
| Vana Papaevanglou | ||
| Nov/2014 – Antwerp, Belgium | 1.4Mb (.pdf) | |
| Russia | ||
| Vladimir Chulanov | ||
| Nov/2014 – Antwerp, Belgium | 1 Mb (.pdf) | |
| Albania | ||
| Silvia Bino | ||
| Nov/2014 – Antwerp, Belgium | 7.9 Mb (.pdf) | |
| lessons learnt from previous thechnical meetings and plans for the future – control of hepatitis C (public health issues) | ||
| Daniel Shouval | ||
| Nov/2014 – Antwerp, Belgium | 1.5 MB (.pdf) | |
| lessons learnt from previous thechnical meetings and plans for the future – Mutants | ||
| Alessandro Zanetti | ||
| Nov/2014 – Antwerp, Belgium | 496 Kb (.pdf) | |
| Hepatitis B: are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries | ||
| Paolo Bonnani | ||
| Nov/2014 – Antwerp, Belgium | 618 Kb (.pdf) | |
| The Netherlands | ||
| Hans Houweling | ||
| Nov/2014 – Antwerp, Belgium | 294 Kb (.pdf) | |
| Scandinavian situation | ||
| Hans Blystad | ||
| Nov/2014 – Antwerp, Belgium | 369 Kb (.pdf) | |
| UK – control and management of CHB | ||
| Howard Thomas | ||
| Nov/2014 – Antwerp, Belgium | 130 Kb (.pdf) | |
| Promoting national hepatitis planning as a key step to a comprehensive approach to hepatitis prevention and care | ||
| Stefan Wiktor | ||
| Nov/2014 – Antwerp, Belgium | 1.5 Mb (.pdf) | |
| Scotland | ||
| Nicola Rowan | ||
| Nov/2014 – Antwerp, Belgium | 777 kB (.pdf) | |
| France | ||
| Françoise Roudot-Thoraval | ||
| Nov/2014 – Antwerp, Belgium | 417 Kb (.pdf) | |
| Presentation of the meeting conclusions | ||
| David FitzSimons | ||
| Nov/2014 – Antwerp, Belgium | 49 Kb (.pdf) | |
| Conclusions of the VHPB Brazil meeting: Prevention and control of viral hepatitis in Brazil and other Latin American countries, lessons learnt and the way forward. | ||
| David FitzSimons | ||
| Mar/2014 – Brasilia, Brazil | 57 kB (.pdf) | |
| Cost of viral hepatitis treatment and challenges | ||
| Fábio Mesquita | ||
| Mar/2014 – Brasilia, Brazil | 966 kB (.pdf) | |
| Logistic problems to face delta hepatitis in the Amazonian countries | ||
| Thor Oliveira Dantas | ||
| Mar/2014 – Brasilia, Brazil | 1.4 Mb (.pdf) | |
| The role of civil society to define national response to viral hepatitis | ||
| Carlos Varaldo | ||
| Mar/2014 – Brasilia, Brazil | 1.9 Mb (.pdf) | |
| Challenges to care viral hepatitis patients in Latin America | ||
| Edison Parise | ||
| Mar/2014 – Brasilia, Brazil | 1.4 Mb (.pdf) | |
| Challenges for viral hepatitis prevention in Latin America | ||
| Laura Alves de Souza | ||
| Mar/2014 – Brasilia, Brazil | 875 Kb (.pdf) | |
| Molecular epidemiology of hepatitis C, B and D infection in Brazilian Amazonia | ||
| Wornei Braga | ||
| Mar/2014 – Brasilia, Brazil | 2.8 Mb (.pdf) | |
| Particular matters of viral hepatitis in the Brazilian Amazon | ||
| Juan Miguel Salcedo | ||
| Mar/2014 – Brasilia, Brazil | 3.5 Mb (.pdf) | |
| HIV and HBV/HCV co-infection | ||
| João Mendonça | ||
| Mar/2014 – Brasilia, Brazil | 434 Kb (.pdf) | |
| Epidemiology of hepatitis C in Brazil | ||
| Evaldo Stanislau | ||
| Mar/2014 – Brasilia, Brazil | 2.4 Mb (.pdf) | |
| Epidemiological heterogeneity of infections with hepatitis B and D viruses in Brazil | ||
| Gilberta Bensabath | ||
| Mar/2014 – Brasilia, Brazil | 1.2 Mb (.pdf) | |
| Epidemiology of Hepatitis A and E in Brazil | ||
| Themis Rebervel Silveira | ||
| Mar/2014 – Brasilia, Brazil | 2.3 Mb (.pdf) | |
| The Brazilian response to viral hepatitis /Brazilian Hepatitis Plan | ||
| Marcelo Naveira | ||
| Mar/2014 – Brasilia, Brazil | 258 Kb (.pdf) | |
| Burden of liver disease in Brazil | ||
| Angelo Alves de Mattos | ||
| Mar/2014 – Brasilia, Brazil | 3.3 Mb (.pdf) | |
| Organization of the public health system in Brazil | ||
| André Bonifácio | ||
| Mar/2014 – Brasilia, Brazil | 808 Kb (.pdf) | |
| The building of a viral hepatitis network in Latin America | ||
| Marcelo Silva | ||
| Mar/2014 – Brasilia, Brazil | 1.7 Mb (.pdf) | |
| Difficulty to implement an integrated Molecular Biology tool in Latin America(exemplified by Brazil). | ||
| Andreas Stöcker | ||
| Mar/2014 – Brasilia, Brazil | 1.1 Mb (.pdf) | |
| Hepatitis E infection in Latin America. | ||
| Angelo Alves de Mattos | ||
| Mar/2014 – Brasilia, Brazil | 3 Mb (.pdf) | |
| Impact of the single-dose immunization strategy against hepatitis A in Argentina. | ||
| Jorge Gonzalez | ||
| Mar/2014 – Brasilia, Brazil | 4.4 Mb (.pdf) | |
| Viral hepatitis issues in Peru | ||
| Carlos Benites | ||
| Mar/2014 – Brasilia, Brazil | 3.9 Mb (.pdf) | |
| Viral hepatitis issues in Caribbean | ||
| Fernando Contreras | ||
| Mar/2014 – Brasilia, Brazil | 748 Kb (.pdf) | |
| Viral hepatitis issues in Argentina | ||
| Gabriela Vidiella | ||
| Mar/2014 – Brasilia, Brazil | 3.4 Mb (.pdf) | |
| Liver transplantation in LA – The Brazilian example | ||
| Paulo Massarollo | ||
| Mar/2014 – Brasilia, Brazil | 3.2 Mb (.pdf) | |
| The burden of hepatocellular carcinoma related to viral hepatitis in Latin America. | ||
| Raymundo Paraná | ||
| Mar/2014 – Brasilia, Brazil | 3.6 Mb (.pdf) | |
| Treatment Guidelines of the Latin American Association for the Study of the Liver | ||
| Nahum Méndez-Sánchez | ||
| Mar/2014 – Brasilia, Brazil | 2.4 Mb (.pdf) | |
| The Brazilian mathematical model | ||
| Marcelo Burattini | ||
| Mar/2014 – Brasilia, Brazil | 1.4 Mb (.pdf) | |
| World HepatitisAlliance – Patient point of view | ||
| Charles Gore | ||
| Mar/2014 – Brasilia, Brazil | 231 Kb (.pdf) | |
| WHO Global Viral Hepatitis plan | ||
| Massimo Ghidinelli | ||
| Mar/2014 – Brasilia, Brazil | 2 Mb (.pdf) | |
| Impact of VHPB meeting in Israel | ||
| Daniel Shouval | ||
| Mar/2014 – Brasilia, Brazil | 1 Mb (.pdf) | |
| Impact of VHPB meeting in Bulgaria | ||
| Mira Kojouharova | ||
| Mar/2014 – Brasilia, Brazil | 615 Kb (.pdf) | |
| Impact of VHPB meeting in Portugal | ||
| Rui Tato Marinho | ||
| Mar/2014 – Brasilia, Brazil | 5 Mb (.pdf) | |
| 22 years VHPB: realisations and impact | ||
| Mark Kane/Johannes Hallauer | ||
| Mar/2014 – Brasilia, Brazil | 2 Mb (.pdf) | |
| Introduction of the VHPB | ||
| Pierre Van Damme | ||
| Mar/2014 – Brasilia, Brazil | 2 Mb (.pdf) | |
| The 2014 Brazilian Resolution at the World Health Assembly | ||
| Fábio Mesquita | ||
| Mar/2014 – Brasilia, Brazil | 322 Kb (.pdf) | |
| Viral hepatitis in Latin America and the Caribbean: a public health challenge | ||
| Massimo Ghidinelli | ||
| Mar/2014 – Brasilia, Brazil | 1.6 Mb (.pdf) | |
| Meeting Conclusion: A new era for screening and treatment of hepatitis C: a public health challenge. | ||
| David FitzSimons | ||
| Nov/2014 – Split, Croatia | 55 Kb (.pdf) | |
| Barriers to hepatitis C treatment | ||
| Philip Bruggmann | ||
| Nov/2014 – Split, Croatia | 1.2 Mb (.pdf) | |
| Prevention of Hepatitis C Virus transmission Among People Who Inject Drugs. | ||
| Sharon Hutchinson | ||
| Nov/2014 – Split, Croatia | 1.2 Mb (.pdf) | |
| Lessons learned from the treatment as prevention approach for HiV applicable to HCV. | ||
| Julio Montaner | ||
| Nov/2014 – Split, Croatia | 6 Mb (.pdf) | |
| Prospects for prophylactic and Therapeutic vaccines against the hepatitis C viruses in the world of improving treatment. | ||
| Jake Liang | ||
| Nov/2014 – Split, Croatia | 4.3 Mb (.pdf) | |
| Mediterranean and Balkan countries: executive summary of the Conference on Hepatitis B and C in Mediterranean and Balkan Countries, Nicosia, Cyprus 5-7 December 2012, organised by hepatitis B and C policy association. (focus on hepatitis C) | ||
| Spilios Manolakopoulos | ||
| Nov/2014 – Split, Croatia | 375 Kb (.pdf) | |
| Country examples of national Hepatitis C controlling programmes: Swedish Consensus Group. Treatment of hepatitis C virus infection in adults and children: updated Swedish consensus recommendations | ||
| Martin Lagging | ||
| Nov/2014 – Split, Croatia | 174 Kb (.pdf) | |
| Country examples of national Hepatitis C controlling programmes: The Netherlands: Hepatitis C treatment guidelines | ||
| Floor Berden | ||
| Nov/2014 – Split, Croatia | 1.5 Mb (.pdf) | |
| Country examples of national Hepatitis C controlling programmes: CROATIA | ||
| Tatjana Reic/ Prof Raiko Ostojic | ||
| Nov/2014 – Split, Croatia | 948 Kb (.pdf) | |
| Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis in Europe. | ||
| Homie Razavi | ||
| Nov/2014 – Split, Croatia | 538 Kb (.pdf) | |
| USA: Public health impact of antiviral therapy for hepatitis C in the United States. | ||
| Michael Volk | ||
| Nov/2014 – Split, Croatia | 103 Kb (.pdf) | |
| HCV Testing Strategies and New Patient Identification in the United States | ||
| David Rein | ||
| Nov/2014 – Split, Croatia | 282 Kb (.pdf) | |
| Hepatitis C Screening: Key Issues and Evidence | ||
| David Goldberg | ||
| Nov/2014 – Split, Croatia | 28 Kb (.pdf) | |
| WHO Hepatitis C Therapeutic guidelines (they will be released before the end of 2013) | ||
| Stefan Wiktor | ||
| Nov/2014 – Split, Croatia | 830 Kb (.pdf) | |
| Market access and uptake of new antiviral drugs for the treatment of hepatitis. | ||
| Homie Razavi | ||
| Nov/2014 – Split, Croatia | 571 Kb (.pdf) | |
| Jake Liang | ||
| Benjamin Maasoumy | ||
| Nov/2014 – Split, Croatia | 1.4 Mb (.pdf) | |
| Overview of current developments in treatment of hepatitis C | ||
| Jake Liang | ||
| Nov/2014 – Split, Croatia | 2.3 Mb (.pdf) | |
| Hepatitis C in United States | ||
| John Ward | ||
| Nov/2014 – Split, Croatia | 1.7 Mb (.pdf) | |
| Presentation on epidemiology of hepatitis C in Europe- incidence, risk population, prevalence, disease burden (cirrhosis, HCC) and mortality | ||
| Erika Duffell | ||
| Mar/2013 – Jerusalem, Israel | 1,456 Kb (.pdf) | |
| Patients Association: HETZ-The Israeli Association for the Health of the Liver. | ||
| Julio Burman | ||
| Mar/2013 – Jerusalem, Israel | 1,900 Kb (.pdf) | |
| Liver Transplantation for viral liver diseases in Israel. | ||
| Michal Carmiel | ||
| Mar/2013 – Jerusalem, Israel | 269 Kb (.pdf) | |
| Molecular epidemiology of hepatitis E in Israel | ||
| Nili Daudi | ||
| Mar/2013 – Jerusalem, Israel | 229 Kb (.pdf) | |
| Prevention and control of viral hepatitis in Israel: lesson learnt and the way forward. Meeting conclusions | ||
| David FitzSimons | ||
| Mar/2013 – Jerusalem, Israel | 67 Kb (.pdf) | |
| An outbreak of hepatitis A in adults in Tel-Aviv district. | ||
| Matthew Lewis | ||
| Mar/2013 – Jerusalem, Israel | 1,614 Kb (.pdf) | |
| HIV and HCV co-infection in Israel. | ||
| Margalit Lorber | ||
| Mar/2013 – Jerusalem, Israel | 1,073 Kb (.pdf) | |
| Epidemiology of HCV and HIV infection in patients with coagulation disorders. | ||
| Yaacov Maor | ||
| Mar/2013 – Jerusalem, Israel | 254 Kb (.pdf) | |
| Treatment policies and access to treatment for chronic hepatitis B and C | ||
| Tal Morginstin | ||
| Mar/2013 – Jerusalem, Israel | 361 Kb (.pdf) | |
| The National Advisory Committee on Immunization and infetious Diseases (NACIID) Israel. | ||
| Schmuel Rishpon | ||
| Mar/2013 – Jerusalem, Israel | 190 Kb (.pdf) | |
| The national hepatitis A vaccination programme and the impact of universal immunization on the molecular epidemiology of HAV infection. | ||
| Daniel Shouval, Ron Dagan | ||
| Mar/2013 – Jerusalem, Israel | 763 Kb (.pdf) | |
| Hepatitis viruses and HIV in intra-venous drug abusers. | ||
| Paula Roska | ||
| Mar/2013 – Jerusalem, Israel | 583 Kb (.pdf) | |
| Prevention and control of HBV and HCV in healthcare workers. | ||
| Bina Rubinowitch | ||
| Mar/2013 – Jerusalem, Israel | 785 Kb (.pdf) | |
| Hepatitis B and C in pregnancy in the Jewish and Arab population | ||
| Rifaat Safadi | ||
| Mar/2013 – Jerusalem, Israel | 2,444 Kb (.pdf) | |
| Epidemiology of hepatitis E in Israel | ||
| Eli Schwartz | ||
| Mar/2013 – Catania, Italy | 1,537 Kb (.pdf) | |
| introduction VHPB | ||
| VHPB Secretariat | ||
| Mar/2013 – Jerusalem, Israel | 1,770 Kb (.pdf) | |
| Evidence for a rising burden of hepatocellular carcinoma in Israel. | ||
| Oren Shibolet | ||
| Mar/2013 – Jerusalem, Israel | 1,993 Kb (.pdf) | |
| Sero-prevalence of HBs antibodies 19 years after introduction of universal vaccination against HBV in Israel. | ||
| Tamar Shohat | ||
| Mar/2013 – Jerusalem, Israel | 591 Kb (.pdf) | |
| Development and utilization of the PreS/S hepatitis B vaccine in Israel. | ||
| Daniel Shouval | ||
| Mar/2013 – Jerusalem, Israel | 4,751 Kb (.pdf) | |
| Epidemiology of hepatitis A in Israel | ||
| Daniel Shouval | ||
| Mar/2013 – Jerusalem, Israel | 1,584 Kb (.pdf) | |
| Concluding remarks on the prevention and control of viral hepatitis A, B and C in Israel 1972-2012. | ||
| Daniel Shouval | ||
| Mar/2013 – Jerusalem, Israel | 190 Kb (.pdf) | |
| Hepatitis A in Jerusalem : An exception which proves the rule? | ||
| Chen Stein-Zamir | ||
| Mar/2013 – Jerusalem, Israel | 1,662 Kb (.pdf) | |
| Hepatitis B vaccines in patients on hemodialysis in Israel | ||
| Talia Weinstein | ||
| Mar/2013 – Jerusalem, Israel | 255 Kb (.pdf) | |
| Epidemiology of hepatitis B and C in Israel | ||
| Eli Zuckerman | ||
| Mar/2013 – Jerusalem, Israel | 314 Kb (.pdf) | |
| Towards a network of influenza stakeholders in Turkey. | ||
| Selim Badur | ||
| Nov/2012 – Barcelona, Spain | 1,399 Kb (.pdf) | |
| Ensuring the willingness to vaccinate and be vaccinated. | ||
| Jean-Pierre Bayens | ||
| Nov/2012 – Barcelona, Spain | 141 Kb (.pdf) | |
| Disparities in influenza vaccination coverage rates in health care workers and the ways to overcome the barriers. | ||
| Patricia Blank | ||
| Nov/2012 – Barcelona, Spain | 2,337 Kb (.pdf) | |
| Overview of current vaccination policies and recommendations in healthcare workers. | ||
| Fortunato Paolo D’Ancona | ||
| Nov/2012 – Barcelona, Spain | 604 Kb (.pdf) | |
| How to reach healthcare workers? Meeting conclusions | ||
| David FitzSimons | ||
| Nov/2012 – Barcelona, Spain | 87 Kb (.pdf) | |
| Mandatory influenza vaccination of healthcare workers: A succesful implementation by a community healthcare system. | ||
| Sheila Huynh | ||
| Nov/2012 – Barcelona, Spain | 1,374 Kb (.pdf) | |
| EMSA – European medical student association: Overview of current vaccination policies (survey). | ||
| EMSA Kathleen Janssen en Evy Vervecken | ||
| Nov/2012 – Barcelona, Spain | 806 Kb (.pdf) | |
| Influenza vaccination: how to reach heatlhcare workers | ||
| Anna Llupia | ||
| Nov/2012 – Barcelona, Spain | 1,667 Kb (.pdf) | |
| knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccination in France. | ||
| Pierre Loulergue | ||
| Nov/2012 – Barcelona, Spain | 421 Kb (.pdf) | |
| Survey of vaccination policies in French healthcare institutions | ||
| Pierre Loulergue | ||
| Nov/2012 – Barcelona, Spain | 250 Kb (.pdf) | |
| Attitudes toward mandatory occupational vaccinations and vaccination coverage against vaccine-preventable diseases of healthcare workers in primary health centres in Greece. | ||
| Helena Maltezou | ||
| Nov/2012 – Barcelona, Spain | 1,590 Kb (.pdf) | |
| Strategies to increase influenza vaccine uptake among healthcare workers in Greece. | ||
| Helena Maltezou | ||
| Nov/2012 – Barcelona, Spain | 1,247 Kb (.pdf) | |
| HproImmune: European project for the promotion of immunization for health professionals. | ||
| Carmen Montano | ||
| Nov/2012 – Barcelona, Spain | 276 Kb (.pdf) | |
| Can we know the immunization status of healthcare workers? Results of a feasability study in hospital trusts, England 2008. | ||
| Lorenzo Pezzoli | ||
| Nov/2012 – Barcelona, Spain | 888 Kb (.pdf) | |
| Launch Euro Hepatitis Care Index. | ||
| Tatjana Reic | ||
| Nov/2012 – Barcelona, Spain | 930 Kb(.pdf) | |
| PAHO’s experience preventing Hepatitis B in the healthcare workforce in Latin America. | ||
| Julietta Rodriguez-Guzman | ||
| Nov/2012 – Barcelona, Spain | 5,764 Kb (.pdf) | |
| Overview of current vaccination policies and recommendations in healthcare Personnel. Center of Disease Control and Prvention (CDC) | ||
| Sarah Schillie | ||
| Nov/2012 – Barcelona, Spain | 402 Kb (.pdf) | |
| Obligatory occupational health check increases vaccination rates among medical students | ||
| Klaus Schmid | ||
| Nov/2012 – Barcelona, Spain | 476 Kb (.pdf) | |
| Introduction of the VHPB | ||
| VHPB secretariat | ||
| Nov/2012 – Barcelona, Spain | 1,759 Kb (.pdf) | |
| Vaccination coverage in healthcare workers in Italy. | ||
| Silvio Tafuri | ||
| Nov/2012 – Barcelona, Spain | 685 Kb (.pdf) | |
| Prevalence of markers for hepatitis B virus and vaccination compliance among medical school students in Italy. | ||
| Andrea Trevisan | ||
| Nov/2012 – Barcelona, Spain | 357 Kb (.pdf) | |
| Immunization for vaccine-preventable diseases: Why aren’t we protecting our students in US? | ||
| David Weber | ||
| Nov/2012 – Barcelona, Spain | 1,327 Kb (.pdf) | |
| Seroprevalence of vaccine preventable and blood transmissible viral infections | ||
| Sabine Wicker | ||
| Nov/2012 – Barcelona, Spain | 1,637 Kb (.pdf) | |
| WHO Global Hepatitis programme | ||
| Stefan Wiktor | ||
| Nov/2012 – Barcelona, Spain | 1,493 Kb (.pdf) | |
| Introduction to the Viral Hepatitis Prevention Board (VHPB) | ||
| VHPB secretariat | ||
| Mar/2012 – Copenhagen, Denmark | 1,817 Kb (.pdf) | |
| Nordic Countries: The health care systems and communicable disease control. | ||
| Hans Blystad | ||
| Mar/2012 – Copenhagen, Denmark | 523 Kb (.pdf) | |
| Norway: Hepatitis surveillance system and epidemiology in Northern Norway. | ||
| Hans Blystad | ||
| Mar/2012 – Copenhagen, Denmark | 197 Kb (.pdf) | |
| Alaska: Long-term hepatitis B immunogenicity studies in Alaska and the impact of vaccination on cirrhosis, chronic hepatitis B and liver cancer. | ||
| Lisa Bulkow | ||
| Mar/2012 – Copenhagen, Denmark | 3,653 Kb (.pdf) | |
| Burden and prevention of viral hepatitis in Arctic region. Meeting conclusions | ||
| David FitzSimons | ||
| Mar/2012 – Copenhagen, Denmark | 57 Kb (.pdf) | |
| Iceland: The health care systems and communicable disease control and hepatitis surveillance | ||
| Thorolfur Gudnason | ||
| Mar/2012 – Copenhagen, Denmark | 585 Kb (.pdf) | |
| Iceland: Epidemiology of viral hepatitis in Iceland. | ||
| Thorolfur Gudnason | ||
| Mar/2012 – Copenhagen, Denmark | 1,669 Kb (.pdf) | |
| Iceland: An interactive central database of vaccinations in Iceland and hepatitis B prevention programme. | ||
| Nicole Guérin | ||
| Mar/2012 – Copenhagen, Denmark | 1,546 Kb (.pdf) | |
| Greenland: Hepatitis Surveillance system and a population -based registry study of infant mortality in Arctic. | ||
| Anders Koch | ||
| Mar/2012 – Copenhagen, Denmark | 907 Kb (.pdf) | |
| Greenland: Molecular epidemiology: Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. | ||
| Anders Koch | ||
| Mar/2012 – Copenhagen, Denmark | 884 Kb (.pdf) | |
| Greenland: Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland. | ||
| Henrik Krarup | ||
| Mar/2012 – Copenhagen, Denmark | 93 Kb (.pdf) | |
| Finland: Hepatitis surveillance system and epidemiology in Northern Finland | ||
| Markky Kuusi | ||
| Mar/2012 – Copenhagen, Denmark | 915 Kb (.pdf) | |
| Greenland: Implementation and effectiveness of hepatitis B strategy in Greenland. | ||
| Karin Ladefoged | ||
| Mar/2012 – Copenhagen, Denmark | 1,086 Kb (.pdf) | |
| Greenland: Effectiveness of the Targeted Hepatitis B Vaccination Program in Greenland. | ||
| Malene Landbo Børresen | ||
| Mar/2012 – Copenhagen, Denmark | 2,375 Kb (.pdf) | |
| Greenland: Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. | ||
| Malene Landbo Børresen | ||
| Mar/2012 – Copenhagen, Denmark | 1,222 Kb (.pdf) | |
| The health care systems and communicable disease control and hepatitis Surveillance in Canada | ||
| Bryce Larke | ||
| Mar/2012 – Copenhagen, Denmark | 2,494 Kb (.pdf) | |
| Canada: Hepatitis Prevention and control in Canada. | ||
| Bryce Larke | ||
| Mar/2012 – Copenhagen, Denmark | 1,209 Kb (.pdf) | |
| Alaska: The health care systems and communicable disease control. | ||
| Brian McMahon | ||
| Mar/2012 – Copenhagen, Denmark | 2,925 Kb (.pdf) | |
| Management of Chronic Hepatitis B and C in Alaska Natives including surveillance for hepatocellular carcinoma | ||
| Brian McMahon | ||
| Mar/2012 – Copenhagen, Denmark | 645 Kb (.pdf) | |
| Alaska: Epidemiology of Viral hepatitis in Alaska. | ||
| Brian McMahon | ||
| Mar/2012 – Copenhagen, Denmark | 775 Kb (.pdf) | |
| Canada: The Epidemiology and Natural History of Viral Hepatitis in the Canadian North. | ||
| Gerald Minuk | ||
| Mar/2012 – Copenhagen, Denmark | 1,035 Kb (.pdf) | |
| Sweden: Hepatitis surveillance system and epidemiology in Northern Sweden. | ||
| Anders Nystedt | ||
| Mar/2012 – Copenhagen, Denmark | 1,924 Kb (.pdf) | |
| Circumpolar Health: improving the health of the indigenous population and role of Circumpolar Health Organizations. | ||
| Alan Parkinson | ||
| Mar/2012 – Copenhagen, Denmark | 6,774 Kb (.pdf) | |
| Greenland: The health care systems, communicable diseases control and introduction of vaccination against Hepatitis B in childhood immunization program. | ||
| Flemming Kleist Stenz | ||
| Mar/2012 – Copenhagen, Denmark | 1,595 Kb (.pdf) | |
| Hepatitis C incidence and prevention activities targeting young people in Norrbotten County, Sweden. | ||
| Ann-Louise Svedberg | ||
| Mar/2012 – Copenhagen, Denmark | 133 Kb (.pdf) | |
| Alaska: Statewide Hepatitis A vaccination program over the last 25 years. | ||
| Timothy Thomas | ||
| Mar/2012 – Copenhagen, Denmark | 242 kb (.pdf) | |
| Alaska: Hepatitis Surveillance system in Alaska, including hepatitis A surveillance. | ||
| Timothy Thomas | ||
| Mar/2012 – Copenhagen, Denmark | 405 Kb (.pdf) | |
| Russia: Epidemiology of viral hepatitis in Russia (Arctic region). | ||
| Andrey Tulisov | ||
| Mar/2012 – Copenhagen, Denmark | 5,432 Kb (.pdf) | |
| Russia: Hepatitis prevention activities in Northern Russia (Arkhangelsk region). | ||
| Andrey Tulisov | ||
| Mar/2012 – Copenhagen, Denmark | 248 Kb (.pdf) | |
| Greenland: DANHEP: clinical hepatitis database in Denmark and Greenland | ||
| Nina Weis | ||
| Mar/2012 – Copenhagen, Denmark | 999 Kb (.pdf) | |
| HAV and HBV vaccination in drug users. | ||
| Alex Vorsters | ||
| Sep/2011 – Brussels, Belgium | 227Kb (.pdf) | |
| Switched memory B cells maintain specific memory independently of serum antibodies | ||
| Rita Carsetti | ||
| Nov/2011 – Milan, Italy | 3,008 Kb (.pdf) | |
| Long-term persistence of T cell memory in Italian vaccinees | ||
| Mario Clerici | ||
| Nov/2011 – Milan, Italy | 635 Kb (.pdf) | |
| Spain: Epidemiology of acute hepatitis B nineteen years after the introduction of universal vaccination of preadolescents in Catalonia (Spain). | ||
| Angela Dominguez | ||
| Nov/2011 – Milan, Italy | 875 Kb (.pdf) | |
| Hepatitis B vaccination: a completed schedule … enough to control HBV lifelong? – meeting conclusions | ||
| David FitzSimons | ||
| Nov/2011 – Milan, Italy | 56 Kb (.pdf) | |
| Phenotypic methods for investigating the impact of variation on HBsAg antigenicity. | ||
| Samreen Ijaz | ||
| Nov/2011 – Milan, Italy | 360 Kb (.pdf) | |
| Humoral and cellular immune responses after hepatitis B (booster) vaccination. How long will immune memory last? | ||
| Wolfgang Jilg | ||
| Nov/2011 – Milan, Italy | 604 Kb (.pdf) | |
| Bulgaria: Impact of the universal newborn HBV vaccination programme: 20 years after. | ||
| Mira Kojouharova | ||
| Nov/2011 – Milan, Italy | 151 Kb (.pdf) | |
| Role of adjuvants on long term immunity. | ||
| Geert Leroux-Roels | ||
| Nov/2011 – Milan, Italy | 2,867 Kb (.pdf) | |
| 30 year follow up study after Hepatitis B vaccination in Alaska. | ||
| Brian McMahon | ||
| Nov/2011 – Milan, Italy | 635 Kb (.pdf) | |
| Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. | ||
| Brian McMahon | ||
| Nov/2011 – Milan, Italy | 153 Kb (.pdf) | |
| Italy: Impact of universal vaccination programmes on the epidemiology of hepatitis B in Italy (SEIEVA results) | ||
| Alfonso Mele | ||
| Nov/2011 – Milan, Italy | 452 Kb (.pdf) | |
| USA: Impact of universal vaccination programmes: surveillance for acute viral hepatitis – United States | ||
| Trudy Murphy | ||
| Nov/2011 – Milan, Italy | 321 Kb (.pdf) | |
| Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in Thailand | ||
| Yong Poovorawan | ||
| Nov/2011 – Milan, Italy | 1,226 Kb (.pdf) | |
| Thailand: Hepatitis B seroprevalence in Thailand: 15 years after hepatitis B vaccine integration into the national expanded programme on immunization. | ||
| Yong Poovorawan | ||
| Nov/2011 – Milan, Italy | 1,683 Kb (.pdf) | |
| Impact of natural boostering on long-term protection against hepatitis B after newborn (HBsAg + mothers) vaccination. | ||
| Ludek Roznovsky | ||
| Nov/2011 – Milan, Italy | 508 Kb (.pdf) | |
| Breakthrough HBV infections in vaccinated people: a ten years surveillance study in Italy | ||
| Maria Elena Tosti | ||
| Nov/2011 – Milan, Italy | 252 Kb (.pdf) | |
| Influencing factors on long-term protection of hepatitis B after infant vaccination | ||
| Marianne van der Sande | ||
| Nov/2011 – Milan, Italy | 384 Kb (.pdf) | |
| VHPB Introduction | ||
| Pierre Van Damme | ||
| Nov/2011 – Milan, Italy | 1,683 Kb (.pdf) | |
| Current CDC Hepatitis B immunization policy. Is there enough evidence for booster policy? | ||
| John Ward | ||
| Nov/2011 – Milan, Italy | 371 Kb (.pdf) | |
| Gambia: 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer | ||
| Hilton Whittle | ||
| Nov/2011 – Milan, Italy | 237 Kb (.pdf) | |
| WHO booster policy –GRADE approach | ||
| Steven Wiersma | ||
| Nov/2011 – Milan, Italy | 873 Kb (.pdf) | |
| Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules. Basis for policy | ||
| Jamie Wilson | ||
| Nov/2011 – Milan, Italy | 2,3 Mb (.pdf) | |
| Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian policy. | ||
| Alessandro Zanetti | ||
| Nov/2011 – Milan, Italy | 92 Kb (.pdf) | |
| Hepatitis B immune memory in children primed with hexavalent vaccines | ||
| Alessandro Zanetti | ||
| Nov/2011 – Milan, Italy | 177 Kb (.pdf) | |
| Phylogenetic reconstruction of two large HAV outbreaks occurring simultaneously in different regions | ||
| Anton Andonov | ||
| Mar/2011 – Sofia, Bulgaria | 1,684 Kb (.pdf) | |
| Treatment and laboratory monitoring of chronic hepatitis patients in Bulgaria | ||
| Krasimir Antonov | ||
| Mar/2011 – Sofia, Bulgaria | 1,769 Kb (.pdf) | |
| Prevention of viral hepatitis transmission through blood transfusions | ||
| Svetla Bakalova | ||
| Mar/2011 – Sofia, Bulgaria | 1,522 Kb (.pdf) | |
| IDU risk group and viral hepatitis | ||
| Violeta Bogdanova | ||
| Mar/2011 – Cannes, France | 2,852 Kb (.pdf) | |
| Burden and prevention of viral hepatitis in Bulgaria – meeting conclusions | ||
| David FitzSimons | ||
| Mar/2011 – Sofia, Bulgaria | 64 Kb (.pdf) | |
| Our experience in prevention by selective immunization agains viral hepatitis A and B of the staff of military medical academy– Bulgaria | ||
| Andrey Galev | ||
| Mar/2011 – Sofia, Bulgaria | 1.8 Mb (.pdf) | |
| Protection of medical staff through hepatitis B vaccination: serological and epidemiological data from hospitals in Bulgaria | ||
| Nina Gatcheva | ||
| Mar/2011 – Sofia, Bulgaria | 1.5 Mb (.pdf) | |
| Viral hepatitis The patients’ impact in Bulgaria (Hepasist) | ||
| Stanimir Hasurdjev | ||
| Mar/2011 – Sofia, Bulgaria | 1.2 Mb (.pdf) | |
| Organisaton and funding of the heath system in Bulgaria | ||
| Tatiana Ivanonva | ||
| Mar/2011 – Sofia, Bulgaria |
1.6 Mb (.pdf) |
|
| Healthcare Policy for vulnerable groups, especially Roma in Bulgaria | ||
| Rossitza Ivanova | ||
| Mar/2011 – Sofia, Bulgaria | 782 Kb (.pdf) | |
| Seroepidemiological study on HBV and HCV prevalence in Bulgaria | ||
| Ani Kevorkian | ||
| Mar/2011 – Sofia, Bulgaria | 1.7 Mb (.pdf) | |
| Epidemiological effectiveness of the Universal newborn HBV vaccination: 20 years after | ||
| Mira Kojouharova | ||
| Mar/2011 – Sofia, Bulgaria | 89 Kb (.pdf) | |
| Hepatitis A in city of Plovdiv in 2006 – outbreak investigation and control measures | ||
| Angel Kunchev, Monika Troyancheva | ||
| Mar/2011 – Sofia, Bulgaria | 1.2 Mb (.pdf) | |
| National hepatitis B vaccination programme: Cost-Benefit assessment of introduction of Universal HBV vaccination of newborns in Bulgaria | ||
| Anna Kurchatova | ||
| Mar/2011 – Sofia, Bulgaria | 454 Kb (.pdf) | |
| Economic analysis of the universal HBV vaccination 20 years after introduction | ||
| Guenka Petrova | ||
| Mar/2011 – Sofia, Bulgaria | 825 Kb (.pdf) | |
| Bulgarian national immunisation programme | ||
| Filipova Radosveta | ||
| Mar/2011 – Sofia, Bulgaria | 657 Kb (.pdf) | |
| Clinical aspects of viral hepatitis | ||
| Tatiana Tcherveniakova | ||
| Mar/2011 – Sofia, Bulgaria | 3.9 Mb (.pdf) | |
| Molecular epidmiology of HBV and HCV in Bulgaria | ||
| Pavel Teoharov | ||
| Mar/2011 – Sofia, Bulgaria | 1.9 Mb (.pdf) | |
| Concept of health mediators-history, job description and mediator’s activities | ||
| Ivailo Tournev | ||
| Mar/2011 – Sofia, Bulgaria | 2.4 Mb (.pdf) | |
| Quality of life of patients with HBV infections- case study SF 36 | ||
| Alexandra Tzenova-Savova | ||
| Mar/2011 – Sofia, Bulgaria | 453 Kb (.pdf) | |
| Introduction of the VHPB | ||
| Pierre Van Damme | ||
| Mar/2011 – Sofia, Bulgaria | 1.4 Mb (.pdf) | |
| Health care-associated viral hepatitis C | ||
| Rossitza Vatcheva-Dobrevska | ||
| Mar/2011 – Sofia, Bulgaria | 1.1 Mb (.pdf) | |
| sero-epidemiology of viral hepatitis in haemodialysis patients and control measures | ||
| Evgueniy Vazelov, Valentin Mushekov | ||
| Mar/2011 – Sofia, Bulgaria | 461 Kb (.pdf) | |
| Epidemiology of Viral Hepatitis in Bulgaria | ||
| Nadezhda Vladimirova | ||
| Mar/2011 – Sofia, Bulgaria | 519 Kb (.pdf) | |
| Impact of the hepatitis resolution adopted by the World Health Assembly (WHA 63.18) | ||
| Steven Wiersma | ||
| Mar/2011 – Sofia, Bulgaria | 236 Kb (.pdf) | |
| Liver transplant and viral hepatitis in Portugal | ||
| Eduardo Barroso | ||
| Nov/2010 – Lisbon, Portugal | 1.6 Mb (.pdf) | |
| Viral hepatitis surveillance systemin Portugal | ||
| Mario Carreira | ||
| Nov/2010 – Lisbon, Portugal | 70 Kb (.pdf) | |
| Viral hepatitis in haemodialysis | ||
| Armando Carvalho | ||
| Nov/2010 – Lisbon, Portugal | 3.3 Mb (.pdf) | |
| Epidemiology of viral hepatitis in pediatric patients (hepatitis B) | ||
| Goncalo Cordeiro Ferreira | ||
| Nov/2010 – Lisbon, Portugal | 76 Kb (.pdf) | |
| Blood bank screening in Portugal | ||
| Gabriel de Olim | ||
| Nov/2010 – Lisbon, Portugal | 575 Kb (.pdf) | |
| Meeting conclusions VHPB meeting Portugal nov 2010 | ||
| David FitzSimons | ||
| Nov/2010 – Lisbon, Portugal | 94 Kb (.pdf) | |
| The epidemiological situation of hepatitis E in Portugal | ||
| Sara Folgado Alberto | ||
| Nov/2010 – Lisbon, Portugal | 560 Kb (.pdf) | |
| Reforms in the health system: “The health Transformation Programme” in Portugal | ||
| Francisco George | ||
| Nov/2010 – Lisbon, Portugal | 419 Kb (.pdf) | |
| Economic aspects of viral hepatitis and liver disease in Portugal | ||
| José Giria | ||
| Nov/2010 – Lisbon, Portugal | 430 Kb (.pdf) | |
| The epidemiology of hepatitis A in Portugal: targeted vaccination versus universal immunization | ||
| Sandra Guedes | ||
| Nov/2010 – Lisbon, Portugal | 249 Kb (.pdf) | |
| Viral hepatitis and pregnancy | ||
| Christina Guerreiro | ||
| Nov/2010 – Lisbon, Portugal | 1.3 Mb (.pdf) | |
| Key note lecture: Viral Hepatitis | ||
| Daniel Lavanchy | ||
| Nov/2010 – Lisbon, Portugal | 702 Kb (.pdf) | |
| Epidemiology of viral hepatitis in pediatric patients (hepatitis C) | ||
| Ana Isabel Lopes | ||
| Nov/2010 – Lisbon, Portugal | 751 Kb (.pdf) | |
| Epidemiological situation of hepatitis B in Portugal | ||
| Rui Tato Marinho | ||
| Nov/2010 – Lisbon, Portugal | 1,682 Kb (.pdf) | |
| Molecular epidemiology of viral hepatitis C in Portugal | ||
| Antonio Martinho | ||
| Nov/2010 – Lisbon, Portugal | 1 Mb (.pdf) | |
| Molecular epidemiology of viral hepatitis B in Portugal | ||
| Ana Paula Mota | ||
| Nov/2010 – Lisbon, Portugal | 903 Kb (.pdf) | |
| The epidemiology of viral hepatitis in Portuguese IV drug addiction | ||
| José Padua | ||
| Nov/2010 – Lisbon, Portugal | 1.3 Mb (.pdf) | |
| The epidemiological situation of hepatitis C in Portugal | ||
| Paula Peixe | ||
| Nov/2010 – Lisbon, Portugal | 675 Kb (.pdf) | |
| Liver Patients association vision and activities | ||
| Emilia Rodrigues | ||
| Nov/2010 – Lisbon, Portugal | 1.6 Mb (.pdf) | |
| Can Portugal learn from France? | ||
| Francoise Roudot-Thoraval | ||
| Nov/2010 – Lisbon, Portugal | 102 Kb (.pdf) | |
| Epidemiology of co-infection (HIV,HCV) in Portugal | ||
| Rui Sarmento e Castro | ||
| Nov/2010 – Lisbon, Portugal | 701 Kb (.pdf) | |
| The syringe exchange programme in Portugal | ||
| Carla Torre | ||
| Nov/2010 – Lisbon, Portugal | 3.3 Mb (.pdf) | |
| HBV immunization policies and lessons learnt afer 10 years | ||
| Paula Valente | ||
| Nov/2010 – Lisbon, Portugal | 558 Kb (.pdf) | |
| Introduction of the VHPB | ||
| Pierre Van Damme | ||
| Nov/2010 – Lisbon, Portugal | 958 Kb (.pdf) | |
| Impact of the adaptation of the hepatitis resolution (WHA 63.18) by the World Health Assembly | ||
| Steven Wiersma | ||
| Nov/2010 – Lisbon, Portugal | 367 Kb (.pdf) | |
| Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. | ||
| Anne Andermann | ||
| Mar/2010 – Budapest, Hungary | 518 Kb (.pdf) | |
| USA | ||
| Geoff Becket | ||
| Mar/2010 – Budapest, Hungary | 907 Kb (.pdf) | |
| Russia | ||
| Vladimir Chulanov | ||
| Mar/2010 – Budapest, Hungary | 463 Kb (.pdf) | |
| Migrant screening: challenges and options | ||
| Rowan Cody | ||
| Mar/2010 – Budapest, Hungary | 58 Kb (.pdf) | |
| Belgium | ||
| Isabelle Colle | ||
| Mar/2010 – Budapest, Hungary | 200 Kb (.pdf) | |
| Screening for chronic kidney disease: Where does Europe go? | ||
| Paul E de Jong | ||
| Mar/2010 – Budapest, Hungary | 954 Kb (.pdf) | |
| Recommendations regarding viral hepatitis care and treatment. Whom to treat-When to treat? | ||
| Geoffrey Dusheiko | ||
| Mar/2010 – Budapest, Hungary | 867 Kb (.pdf) | |
| Meeting conclusions | ||
| David FitzSimons | ||
| Mar/2010 – Budapest, Hungary | 85 Kb (.pdf) | |
| Scotland | ||
| David Goldberg | ||
| Mar/2010 – Budapest, Hungary | 302 kB (.pdf) | |
| United Kingdom | ||
| William Irving | ||
| Mar/2010 – Budapest, Hungary | 118 kB (.pdf) | |
| Introduction of the VHPB | ||
| Mark Kane | ||
| Mar/2010 – Budapest, Hungary | 716 Kb (.pdf) | |
| Alaska | ||
| Brian McMahon | ||
| Mar/2010 – Budapest, Hungary | 622 Kb (.pdf) | |
| Institute of Medicine (IOM) | ||
| Brian McMahon | ||
| Mar/2010 – Budapest, Hungary | 820 Kb (.pdf) | |
| Surveillance data and case definitions to define the burden of disease in Europe | ||
| David Mercer | ||
| Mar/2010 – Budapest, Hungary | 544 Kb (.pdf) | |
| ELPA | ||
| Nadine Piorkowsky | ||
| Mar/2010 – Budapest, Hungary | 742 Kb (.pdf) | |
| Italy | ||
| Daniele Prati | ||
| Mar/2010 – Budapest, Hungary | 585 Kb (.pdf) | |
| France | ||
| Francoise Roudot-Thoraval | ||
| Mar/2010 – | 793 Kb (.pdf) | |
| Need for long term evaluation of therapy | ||
| Solko Schalm | ||
| Mar/2010 – Budapest, Hungary | 469 Kb (.pdf) | |
| Long term effectiveness and cost-effectiveness of screening of hepatitis C virus infection. | ||
| Gaby Sroczynski | ||
| Mar/2010 – Budapest, Hungary | 425 Kb (.pdf) | |
| EASL | ||
| Heiner Wedemeyer | ||
| Mar/2010 – Budapest, Hungary | 1,753 Kb (.pdf) | |
| update on treatment for hepatitis B and C | ||
| Heiner Wedemeyer | ||
| Mar/2010 – Budapest, Hungary | 1,293 Kb (.pdf) | |
| WHO | ||
| Steven Wiersma | ||
| Mar/2010 – Budapest, Hungary | 420 Kb (.pdf) | |
| Burden of disease of viral hepatitis | ||
| Steven Wiersma | ||
| Mar/2010 – Budapest, Hungary | 775 Kb (.pdf) | |
| Economics of chronic hepatitis B and hepatitis C | ||
| John wong | ||
| Mar/2010 – Budapest, Hungary | 486 Kb (.pdf) | |
| Introduction of the VHPB | ||
| , Pierre Van Damme | ||
| Nov/2009 – Istanbul, Turkey | 646 Kb (.pdf) | |
| Molecular epidemiology of viral hepatitis in Turkey | ||
| Hakan Abacioglu | ||
| Nov/2009 – Istanbul, Turkey | 3.7 Mb (.pdf) | |
| Mutants problems in Turkey | ||
| Ulus Akarca | ||
| Nov/2009 – Istanbul, Turkey | 1 Mb (.pdf) | |
| Economic aspects of viral hepatitis in Turkey | ||
| Levent Akin | ||
| Nov/2009 – Istanbul, Turkey | 874 Kb (.pdf) | |
| Therapeutic algorithm in the treatment of chronic hepatitis in Turkey | ||
| Yilmaz Cakaloglu | ||
| Nov/2009 – Istanbul, Turkey | 485 Kb (.pdf) | |
| The hepatitis A vaccination in Turkey: targeted versus universal | ||
| Mehmet Ceyhan | ||
| Nov/2009 – Istanbul, Turkey | 1,169 Kb (.pdf) | |
| Victimes of human trafficking and viral hepatitis | ||
| Muhtar Cokar | ||
| Nov/2009 – Kyiv, Ukraine | 888 Kb (.pdf) | |
| Healthcare workers and viral hepatitis | ||
| Bulent Degertekin | ||
| Nov/2009 – Istanbul, Turkey | 478 Kb (.pdf) | |
| HBV prevention and control programmes in Turkey and in the European Region of WHO | ||
| Nedret Emiroglu | ||
| Nov/2009 – Istanbul, Turkey | 671 Kb (.pdf) | |
| The epidemiological situation of hepatitis C in Turkey | ||
| Selda Erensoy | ||
| Nov/2009 – Istanbul, Turkey | 1.2 Mb (.pdf) | |
| Conclusions VHPB Turkey meeting 2009 | ||
| David FitzSimons | ||
| Nov/2009 – Istanbul, Turkey | 87 Kb (.pdf) | |
| Results from the blood bank screening in Turkey | ||
| Yasemin Heper | ||
| Nov/2009 – Istanbul, Turkey | 284 Kb (.pdf) | |
| Viral hepatitis and Transplantation. | ||
| Zeki Karasu | ||
| Nov/2009 – Istanbul, Turkey | 1.8 Mb (.pdf) | |
| Global HCV prevention and control measures: lesson learnt and opportunities | ||
| Daniel Lavanchy | ||
| Nov/2009 – Istanbul, Turkey | 403 Kb (.pdf) | |
| Speeding-up Hepatitis B and C control in WHO Eastern Mediterranean Region | ||
| Ezzedine Mohsni | ||
| Nov/2009 – Istanbul, Turkey | 2.9 Mb (.pdf) | |
| HBV immunization policies and lessons learnt after 10 years of implementation | ||
| Umit Ozdemirer | ||
| Nov/2009 – Istanbul, Turkey | 2.4 Mb (.pdf) | |
| Communicable diseases surveillance systems and immunization service delivery | ||
| Umit Ozedemirer | ||
| Nov/2009 – Istanbul, Turkey | 881 Kb (.pdf) | |
| The epidemiological situation of hepatitis B and D in Turkey | ||
| Arzu Sayiner | ||
| Nov/2009 – Istanbul, Turkey | 706 Kb (.pdf) | |
| Approach of NGO’s | ||
| Nurdan Tozun | ||
| Nov/2009 – Istanbul, Turkey | 934 Kb (.pdf) | |
| Epidemiology of chronic hepatitis and cirrhosis in Turkey | ||
| Cihan Yurdaydin | ||
| Nov/2009 – Istanbul, Turkey | 2.1 Mb (.pdf) | |
| Increase in Hepatitis A cases in the Czech Republic in 2008 | ||
| J Cástková | ||
| Mar/2009 – Antwerp, Belgium | 270 Kb (.pdf) | |
| Autochthonous hepatitis E in Southwest England. | ||
| Harry R Dalton | ||
| Mar/2009 – Antwerp, Belgium | 460 Kb (.pdf) | |
| Non-travel related Hepatitis E virus infections in the Netherlands. | ||
| Erwin Duizer | ||
| Mar/2009 – Antwerp, Belgium | 471 Kb (.pdf) | |
| Presentation of the VHPB meeting conclusions. | ||
| David FitzSimons | ||
| Mar/2009 – Antwerp, Belgium | 128 Kb (.pdf) | |
| Prevalence of hepatitis E virus infection in children in Northeast of Spain. | ||
| Rosina Girones | ||
| Mar/2009 – | 137 Kb (.pdf) | |
| Distribution of hepatitis E virus in the environment. | ||
| Rosina Girones | ||
| Mar/2009 – Antwerp, Belgium | 988 Kb (.pdf) | |
| Hepatitis E in Asian Region. | ||
| Emily Gurley | ||
| Mar/2009 – Antwerp, Belgium | 3.9 Mb (.pdf) | |
| Safety and efficacy of a recombinant hepatitis E vaccine. | ||
| Bruce Innis | ||
| Mar/2009 – Antwerp, Belgium | 194 Kb (.pdf) | |
| Hepatitis E Virus Infection in Germany | ||
| Wolfgang Jilg | ||
| Mar/2009 – Antwerp, Belgium | 173 Kb (.pdf) | |
| Hepatitis E virus and chronic hepatitis in organ-transplant recipients. | ||
| Nassim Kamar | ||
| Mar/2009 – Antwerp, Belgium | 1.5 Mb (.pdf) | |
| Pathogenesis and natural history of hepatitis E. | ||
| Krzysztof Krawczynski | ||
| Mar/2009 – Antwerp, Belgium | 1.2 Mb (.pdf) | |
| Acute hepatitis E in south-west France over a 5-year period | ||
| Jean Michel Mansuy | ||
| Mar/2009 – Antwerp, Belgium | 655 Kb (.pdf) | |
| Update on Hepatitis A epidemiology and prevention in WHO European Region | ||
| David Mercer | ||
| Mar/2009 – Antwerp, Belgium | 132 Kb (.pdf) | |
| The seroprevalence of HEV in the National Health and Nutrition Sample of the United States population. | ||
| Kenrad Nelson | ||
| Mar/2009 – Antwerp, Belgium | 646 Kb (.pdf) | |
| Molecular epidemiology of hepatitis E, taxonomy, molecular biology,genotypes and subtypes | ||
| Helene Norder | ||
| Mar/2009 – Antwerp, Belgium | 299 Kb (.pdf) | |
| EVENT, a network for harmonization typing of HAV and for alerting on hepatitis A outbreaks. | ||
| Helene Norder | ||
| Mar/2009 – Antwerp, Belgium | 110 Kb (.pdf) | |
| Hepatitis E: a curious zoönosis | ||
| Nicole Pavio | ||
| Mar/2009 – Antwerp, Belgium | 753 Kb (.pdf) | |
| Community-wide outbreak of Hepatitis A in Latvia | ||
| J Perevoscikovs | ||
| Mar/2009 – Antwerp, Belgium | 2.8 Mb (.pdf) | |
| Hepatitis E from A to Z: Discovery and Characterization | ||
| Robert Purcell | ||
| Mar/2009 – Antwerp, Belgium | 2.9 Mb (.pdf) | |
| Global overview on the effectiveness of Hepatitis A vaccination programs | ||
| Umid Sharapov | ||
| Mar/2009 – Antwerp, Belgium | 622 Kb (.pdf) | |
| Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. | ||
| James Wai-kuo Shih | ||
| Mar/2009 – Antwerp, Belgium | 1 Mg (.pdf) | |
| What are the risk factors with an impact on fatality rate in fulminant hepatitis A? | ||
| Daniel Shouval | ||
| Mar/2009 – Antwerp, Belgium | 536 Kb (.pdf) | |
| Hepatitis E vaccine: Clinical experience | ||
| Mrigendra Shrestha | ||
| Mar/2009 – Antwerp, Belgium | 716 Kb (.pdf) | |
| Long-term immunity induced by hepatitis A vaccines: an update | ||
| Koen Van Herck | ||
| Mar/2009 – Antwerp, Belgium | 263 Kb (.pdf) | |
| Summary of major findings and conclusions of Global Hepatitis A meeting, Miami dec. 2007 | ||
| Pierre Van Damme | ||
| Mar/2009 – Antwerp, Belgium | 562 Kb (.pdf) | |
| Introduction of the VHPB | ||
| Pierre Van Damme | ||
| Mar/2009 – Antwerp, Belgium | 1.2 MB (.pdf) | |
| Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after Hepatitis A vaccination in high and low responder. | ||
| Ursula Wiedermann | ||
| Mar/2009 – Antwerp, Belgium | 771 kB (.pdf) | |
| Review of the Hepatitis A WHO position paper: need for an update? | ||
| Steven Wiersma | ||
| Mar/2009 – Antwerp, Belgium | 196 kB (.pdf) | |
| Hepatitis E in Italy | ||
| Alessandro Zanetti | ||
| Mar/2009 – Antwerp, Belgium | 360 Kb (.pdf) | |
| Pregnancy and viral hepatitis. | ||
| Greet Boland | ||
| Nov/2008 – Rotterdam, The Netherlands | 338 Kb (.pdf) | |
| Molecular epidemiology of HBV infection in The Netherlands. | ||
| Hein Boot | ||
| Nov/2008 – Rotterdam, The Netherlands | 375 Kb (.pdf) | |
| Approach to the different risk groups for HBV and/or HCV. | ||
| Robert de Knegt | ||
| Nov/2008 – Rotterdam, The Netherlands | 477 Kb (.pdf) | |
| Update on prevention and control of hepatitis B in WHO European Region. | ||
| Nedret Emiroglu | ||
| Nov/2008 – Rotterdam, The Netherlands | 509 Kb (.pdf) | |
| Presentation of the VHPB meeting conclusions | ||
| David FitzSimons | ||
| Nov/2008 – Rotterdam, The Netherlands | 142 Kb (.pdf) | |
| Overview of HAV, HBV, HCV surveillance in The Netherlands | ||
| Susan Hahné | ||
| Nov/2008 – Rotterdam, The Netherlands | 389 Kb (.pdf) | |
| Hepatitis B vaccination in The Netherlands: Risk group approach. | ||
| Susan Hahné | ||
| Nov/2008 – Rotterdam, The Netherlands | 450 Kb (.pdf) | |
| National immunisation program and viral hepatitis immunisation policies. | ||
| Hans Houweling | ||
| Nov/2008 – Rotterdam, The Netherlands | 1 Mb (.pdf) | |
| Need for chronic viral hepatitis monitoring system. | ||
| Harry Janssen | ||
| Nov/2008 – Rotterdam, The Netherlands | 1 Mb (.pdf) | |
| Epidemiology of hepatitis B infection in The Netherlands. | ||
| Myriam Kretzschmar | ||
| Nov/2008 – Kyiv, Ukraine | 847 Kb (.pdf) | |
| National program and epidemiology of hepatitis C in the Netherlands. | ||
| Henk Reesink | ||
| Nov/2008 – Edinburgh, United Kingdom | 279 Kb (.pdf) | |
| Hepatitis B vaccination in The Netherlands: Universal approach | ||
| Clemence Richter | ||
| Nov/2008 – Rotterdam, The Netherlands | 474 Kb (.pdf) | |
| Mortality from viral hepatitis in The Netherlands | ||
| Solko Schalm | ||
| Nov/2008 – Rotterdam, The Netherlands | 382 Kb (.pdf) | |
| Epidemiology of Hepatitis C infections in The Netherlands. | ||
| Serena Slavenburg | ||
| Nov/2008 – Rotterdam, The Netherlands | 383 Kb (.pdf) | |
| Molecular epidemiology of HCV infection in The Netherlands | ||
| Thijs van de Laar | ||
| Nov/2008 – Rotterdam, The Netherlands | 530 Kb (.pdf) | |
| Epidemiology of hepatitis A and E in The Netherlands. | ||
| Jim van Steenbergen | ||
| Nov/2008 – Rotterdam, The Netherlands | 1 Mb (.pdf) | |
| Limited control of Hepatitis A by decentralized vaccination strategies | ||
| Jim van Steenbergen | ||
| Nov/2008 – Rotterdam, The Netherlands | 234 Kb (.pdf) | |
| Introduction of the VHPB. | ||
| Pierre Van Damme | ||
| Nov/2008 – Rotterdam, The Netherlands | 1 Mb (.pdf) | |
| Screening of migrants. | ||
| Irene Veldhuijzen | ||
| Nov/2008 – Rotterdam, The Netherlands | 399 Kb (.pdf) | |
| Migration and viral hepatitis. | ||
| Tania Wörmann | ||
| Nov/2008 – Rotterdam, The Netherlands | 686 Kb (.pdf) | |
| Health care-associated viral hepatitis. | ||
| Hans Zaaijer | ||
| Nov/2008 – Rotterdam, The Netherlands | 275 Kb (.pdf) | |
| Belgium: Carrefour Hépatites-Aide et Contact // Vereniging voor hepatitis C patienten. | ||
| Muriel Colinet, Marie-Fabienne Van den Berghe | ||
| Mar/2008 – Lucca, Italy | 945 Kb (.pdf) | |
| Presentation of the VHPB meeting conclusions. | ||
| David FitzSimons | ||
| Mar/2008 – Lucca, Italy | 75 Kb (.pdf) | |
| Italy: EpaC | ||
| Ivan Gardini | ||
| Mar/2008 – Lucca, Italy | 634 Kb (.pdf) | |
| Hepatitis B priority area for European policy; Call for action by the European Parliament. | ||
| Charles Gore | ||
| Mar/2008 – Lucca, Italy | 81 Kb (.pdf) | |
| World Hepatitis Day (WHD). | ||
| Charles Gore | ||
| Mar/2008 – Lucca, Italy | 56 Kb (.pdf) | |
| Bulgaria: Hepasist. | ||
| Stanimir Hasurdjiev | ||
| Mar/2008 – Lucca, Italy | 5,984 Kb (.pdf) | |
| Relationship between industry and patient organisations: European Federation of Pharmaceutical industries and associations (EFPIA) ethical code. | ||
| Luc Hessel | ||
| Mar/2008 – Lucca, Italy | 511 Kb (.pdf) | |
| Germany: Deutsche Leberhilfe. | ||
| Achim Kautz | ||
| Mar/2008 – Lucca, Italy | 54 Kb (.pdf) | |
| US: The Hepatitis Foundation International. | ||
| Thelma King Thiel | ||
| Mar/2008 – Lucca, Italy | 61 Kb (.pdf) | |
| European patient groups for rare diseases. | ||
| Michele Lipucci di Paola | ||
| Mar/2008 – Lucca, Italy | 810 Kb (.pdf) | |
| UK: British Liver Trust . | ||
| Sarah Matthews | ||
| Mar/2008 – Lucca, Italy | 470 Kb (.pdf) | |
| Update on prevention and control of hepatitis B in WHO European Region. | ||
| Liudmila Mosina | ||
| Mar/2008 – Lucca, Italy | 1,022 Kb (.pdf) | |
| The European Immunization Week | ||
| Liudmila Mosina | ||
| Mar/2008 – Lucca, Italy | 856 Kb (.pdf) | |
| Prevention and control of viral hepatitis; the role and impact of liver patient groups in Europe: general considerations. | ||
| Nadine Piorkowsky | ||
| Mar/2008 – Lucca, Italy | 308 Kb (.pdf) | |
| Croatia: Hepatos. | ||
| Tatjana Reic | ||
| Mar/2008 – Lucca, Italy | 356 Kb (.pdf) | |
| Poland: Prometeuze. | ||
| Ilona Sikorska | ||
| Mar/2008 – Lucca, Italy | 75 Kb (.pdf) | |
| Advocating for immigrant communities at risk. | ||
| Samuel So | ||
| Mar/2008 – Lucca, Italy | 1.3 Mb (.pdf) | |
| The Netherlands : National Hepatitis Centre. | ||
| Paula Van Leeuwen | ||
| Mar/2008 – Lucca, Italy | 77 Kb (.pdf) | |
| Introduction of the VHPB | ||
| Pierre Van Damme | ||
| Mar/2008 – Lucca, Italy | 423 Kb (.pdf) | |
| Prevention and control of viral hepatitis in the US; the National Viral Hepatitis Roundtable. | ||
| Deborah L. Wexler | ||
| Mar/2008 – Lucca, Italy | 1.4 Mb (.pdf) | |
| Viral hepatitis coinfection in HIV-infected patients | ||
| Ioannis Baraboutis | ||
| Nov/2007 – Athens, Greece | 1.2 Mb (.pdf) | |
| Cohort of HBV and HCV patients | ||
| Emanuel Manesis | ||
| Nov/2007 – Athens, Greece | 448 Kb (.pdf) | |
| EUVAC.NET’s activities: Expectations and results | ||
| Mark Muscat | ||
| Nov/2007 – Athens, Greece | 1.2 Mb (.pdf) | |
| Viral hepatitis A, B and C surveillance in Greece | ||
| Georgia Nikolopoulo | ||
| Nov/2007 – Athens, Greece | 316 Kb (.pdf) | |
| Hepatitis B and hepatitis A vaccination uptake in the child population of Greece | ||
| Takis Panagiotopoulos | ||
| Nov/2007 – Athens, Greece | 196 Kb (.pdf) | |
| Epidemiology of hepatitis B and D in Greece | ||
| George Papaetheodoridis | ||
| Nov/2007 – Athens, Greece | 355 Kb (.pdf) | |
| Hepatitis B immunization policies | ||
| Vassiliki Papaevangelou | ||
| Nov/2007 – Athens, Greece | 198 Kb (.pdf) | |
| The hepatitis A vaccination program in Greece: Targeted versus universal immunization | ||
| Vassiliki Papaevangelou | ||
| Nov/2007 – Athens, Greece | 449 Kb (.pdf) | |
| Epidemiology of hepatitis A and E in Greece | ||
| Vassiliki Papaevangelou | ||
| Nov/2007 – Athens, Greece | 281 Kb (.pdf) | |
| Molecular epidemiology of HBV and HCV in Greece | ||
| Dimitros Paraskevis | ||
| Nov/2007 – Athens, Greece | 3 Mb (.pdf) | |
| Universal vaccination against hepatitis A: Lessons from the experience in Immunization of toddlers in Israel | ||
| Daniel Shouval | ||
| Nov/2007 – Athens, Greece | 316 Kb (.pdf) | |
| National seroprevalence study: Discussion of different approaches. | ||
| Giota Touloumi | ||
| Nov/2007 – Athens, Greece | 235 Kb (.pdf) | |
| Organization of the health care system and financement in Greece | ||
| Yannis Tountas | ||
| Nov/2007 – Athens, Greece | 275 Kb (.pdf) | |
| Experience gained from surveillance of infectious diseases during the Olympics. How can we extend it to real life? | ||
| Sotirios Tsiodras | ||
| Nov/2007 – Athens, Greece | 951 Kb (.pdf) | |
| Introduction of the Viral Hepatitis Prevention Board (VHPB). | ||
| Pierre Van Damme | ||
| Nov/2007 – Athens, Greece | 366 Kb (.pdf) | |
| Prevention and control of viral hepatitis virus in Greece: Lessons learnt and the way forward | ||
| Pierre Van Damme | ||
| Nov/2007 – Athens, Greece | 181 Kb (.pdf) | |
| Surveillance in blood bank in Greece | ||
| Agoritsa Varaklioti | ||
| Nov/2007 – Athens, Greece | 240 Kb (.pdf) | |
| Migration and viral hepatitis | ||
| Vasiliki Vasilopoulou | ||
| Nov/2007 – Athens, Greece | 205 Kb (.pdf) | |
| National program for viral hepatitis prevention and control | ||
| Anastasia Zisouli | ||
| Nov/2007 – Athens, Greece | 247 Kb (.pdf) | |
| Introduction of the Hellenic Centre for Infectious Disease Control (KEEL) | ||
| Anastasia Zisouli | ||
| Nov/2007 – Athens, Greece | 29 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Turkey. | ||
| Selim Badur | ||
| Mar/2007 – Ljubljana, Slovenia | 63 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Italy. | ||
| Paolo Bonanni | ||
| Mar/2007 – Ljubljana, Slovenia | 94 Kb (.pdf) | |
| Gaps in knowledge on adolescent health. | ||
| Ueli Bühlmann | ||
| Mar/2007 – Ljubljana, Slovenia | 555 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in The Netherlands. | ||
| Rudy Burgmeijer | ||
| Mar/2007 – Ljubljana, Slovenia | 655 Kb (.pdf) | |
| Vaccination at school – future challenges | ||
| Claire Cameron | ||
| Mar/2007 – Ljubljana, Slovenia | 316 Kb (.pdf) | |
| Prevention and control of viral hepatitis through adolescent health programmes in Europe: Conclusions and summary of the meeting. | ||
| David FitzSimons | ||
| Mar/2007 – Ljubljana, Slovenia | 67 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in the UK. | ||
| Roger Harrington | ||
| Mar/2007 – Ljubljana, Slovenia | 178 Kb (.pdf) | |
| Adolescent and vaccination: Knowledge and perception. | ||
| Luc Hessel | ||
| Mar/2007 – Ljubljana, Slovenia | 864 Kb (.pdf) | |
| Introduction of European Union for School and Univeristy Health and Medicine (EUSUHM). | ||
| Karel Hoppenbrouwers | ||
| Mar/2007 – Ljubljana, Slovenia | 63 kB (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Belgium | ||
| Karel Hoppenbrouwers | ||
| Mar/2007 – Ljubljana, Slovenia | 90 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Finland. | ||
| Kaarina Jävenpää | ||
| Mar/2007 – Ljubljana, Slovenia | 167 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Slovenia. | ||
| Mojca Juricic | ||
| Mar/2007 – Ljubljana, Slovenia | 239 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Rep of Macedonia. | ||
| Mimi Karovska | ||
| Mar/2007 – Ljubljana, Slovenia | 602 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Croatia. | ||
| Marina Kuzman | ||
| Mar/2007 – Ljubljana, Slovenia | 386 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Norway. | ||
| Hanne Nokleby | ||
| Mar/2007 – Ljubljana, Slovenia | 67 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Greece. | ||
| Vassiliki Papaevangelou | ||
| Mar/2007 – Ljubljana, Slovenia | 55 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Germany | ||
| Matthias Pulz | ||
| Mar/2007 – Ljubljana, Slovenia | 214 Kb (.pdf) | |
| Issues in implementing hepatitis B vaccination in adolescents. | ||
| Susan Rosenthal | ||
| Mar/2007 – Ljubljana, Slovenia | 309 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in France. | ||
| Francoise Roudot-Thoraval, Nicole Guérin | ||
| Mar/2007 – Ljubljana, Slovenia | 87 Kb (.pdf) | |
| WHO and Adolescent Immunization | ||
| Craig Shapiro | ||
| Mar/2007 – Ljubljana, Slovenia | 461 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Hungary. | ||
| Tamas Simon | ||
| Mar/2007 – Ljubljana, Slovenia | 60 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in Switzerland. | ||
| Susanne Stronski | ||
| Mar/2007 – Ljubljana, Slovenia | 445 Kb (.pdf) | |
| Introduction of the Viral Hepatitis Prevention Board (VHPB). | ||
| Pierre Van Damme | ||
| Mar/2007 – Ljubljana, Slovenia | 200 Kb (.pdf) | |
| Adolescent health programme and its contribution to the success of vaccination in the US. | ||
| John Ward | ||
| Mar/2007 – Ljubljana, Slovenia | 506 Kb (.pdf) | |
| Hepatitis B Virus Genetic diversity in Spain. | ||
| Ana Avellon | ||
| Nov/2006 – Madrid, Spain | 1.7 Mb (.pdf) | |
| Epidemiology of Hepatitis C Infection | ||
| Pablo Barreiro | ||
| Nov/2006 – Madrid, Spain | 1.1 Mb (.pdf) | |
| Epidemiological Surveillance of HCV Infection in Spanish Dialysis Units | ||
| Guillermina Barril | ||
| Nov/2006 – Madrid, Spain | 1.9 Mb (.pdf) | |
| Molecular diagnosis of hepatitis B infection in the transfusional setting | ||
| Emma Castro | ||
| Nov/2006 – Madrid, Spain | 183 Kb (.pdf) | |
| Prevalence of HCV-HIV co-infection among mothers of newborn babies | ||
| Mercedes Diez | ||
| Nov/2006 – Madrid, Spain | 324 Kb (.pdf) | |
| Vaccination against hepatitis A in Catalonia | ||
| Angela Dominguez | ||
| Nov/2006 – Madrid, Spain | 177 Kb (.pdf) | |
| Molecular Epidemiology of Hepatitis A and E viruses | ||
| Rosina Girones | ||
| Nov/2006 – Madrid, Spain | 732 Kb (.pdf) | |
| Outbreaks of hepatitis A in Spain | ||
| Dionisio José Herrera Guibert | ||
| Nov/2006 – Madrid, Spain | 851 Kb (.pdf) | |
| Hepatits E virus infections in Spain | ||
| Maria Teresa Perez Gracia | ||
| Nov/2006 – Madrid, Spain | 2.1 Mb (.pdf) | |
| Molecular epidemiology of HCV | ||
| Josep Quer | ||
| Nov/2006 – Madrid, Spain | 1 Mb (.pdf) | |
| Treatment of chronic hepatitis B | ||
| José M Sanchez Tapias | ||
| Nov/2006 – Madrid, Spain | 126 Kb (.pdf) | |
| Treatment of chronic hepatitis C | ||
| José M Sanchez Tapias | ||
| Nov/2006 – Madrid, Spain | 169 Kb (.pdf) | |
| Hepatitis vaccination policy in Spain | ||
| Patricia Santa Olalla Peralta | ||
| Nov/2006 – Madrid, Spain | 190 Kb (.pdf) | |
| Organization of the health care system in Spain | ||
| Patricia Santa Olalla Peralta | ||
| Nov/2006 – Madrid, Spain | 390 Kb (.pdf) | |
| Prevention and control of viral hepatitis virus in Spain: Lessons learnt and the way forward. Conclusions | ||
| Daniel Shouval | ||
| Nov/2006 – Madrid, Spain | 32 Kb (.pdf) | |
| National Epidemiological Surveillance Network: Hepatitis | ||
| Carmen Varela Martinez | ||
| Nov/2006 – Madrid, Spain | 1 Mb (.pdf) | |
| Effectiveness of newborn hepatitis B vaccination programmes | ||
| Francis André | ||
| Mar/2006 – Istanbul, Turkey | 1.1 Mb (.pdf) | |
| Are immunogenicity and protective efficacy of hepatitis B vaccine related to different administration schedules? | ||
| Voranush Chongsrisawat | ||
| Mar/2006 – Istanbul, Turkey | 625 Kb (.pdf) | |
| Overview of HBV Infections and the vaccination policy in Turkey | ||
| Meral Ciblak, Selim Badur | ||
| Mar/2006 – Istanbul, Turkey | 532 Kb (.pdf) | |
| Prevention and control of perinatal hepatitis B virus transmission in the WHO European Region Introduction | ||
| Nedret Emiroglu | ||
| Mar/2006 – Istanbul, Turkey | 85 Kb (.pdf) | |
| Prevention of perinatal HBV transmission: Evaluation of programs and success stories from Central Asia and Kazakhstan | ||
| Michael Favorov | ||
| Mar/2006 – Istanbul, Turkey | 1.8 Mb (.pdf) | |
| Prevention and control of perinatal hepatitis B virus (HBV) transmission in the WHO European Region: Conclusions and summary of the meeting | ||
| David FitzSimons | ||
| Mar/2006 – Istanbul, Turkey | 121 Kb (.pdf) | |
| Prevention and control of HBV perinatal transmission in Armenia | ||
| Armen Hayrapetyan | ||
| Mar/2006 – Istanbul, Turkey | 967 Kb (.pdf) | |
| Long term efficacy of hepatitis B vaccination of newborns from HBs Ag positive mothers in Thailand | ||
| Bernard Hoet | ||
| Mar/2006 – Istanbul, Turkey | 58 kb (.pdf) | |
| Prevention and control of perinatal transmission of hepatitis B virus: Situation and experience in Georgia | ||
| Paata Imnadze | ||
| Mar/2006 – Istanbul, Turkey | 656 Kb (.pdf) | |
| Prevention and control of perinatal hepatitis B virus: situation and experience in Tajikistan | ||
| Shamsiddin Jabirov | ||
| Mar/2006 – Istanbul, Turkey | 873 Kb (.pdf) | |
| Prevention and control of perinatal hepatitis B virus transmission in the Republic of Kyrgyzstan | ||
| Joldosh Kalilov | ||
| Mar/2006 – Istanbul, Turkey | 264 Kb (.pdf) | |
| The main modes of HBV transmission in children, Central Asian Region | ||
| Liudmila Mosina | ||
| Mar/2006 – Istanbul, Turkey | 1.7 Mb (.pdf) | |
| Prevention and control of perinatal transmission of viral hepatitis B: Uzbekistan experience | ||
| Irkin Musabaev | ||
| Mar/2006 – Istanbul, Turkey | 1.9 Mb (.pdf) | |
| Improving the hepatitis B birth dose in Indonesia, Vietnam, and Cambodia | ||
| Carib Nelson | ||
| Mar/2006 – Istanbul, Turkey | 1 Mb (.pdf) | |
| Hepatitis B vaccination and HBIg administration policies implemented for premature babies – vaccines concurrently administrated with the hepatitis B vaccine birth dose | ||
| Vassiliki Papaevangelou | ||
| Mar/2006 – Istanbul, Turkey | 530 Kb (.pdf) | |
| Hepatitis B vaccination of newborns in rural China: evaluation of an out-of-cold-chain delivery strategy | ||
| Lixia Wang | ||
| Mar/2006 – Istanbul, Turkey | 590 Kb (.pdf) | |
| Hepatitis B disease burden: a model for global estimates and impact of vaccination | ||
| Susan Wang | ||
| Mar/2006 – Istanbul, Turkey | 131 Kb (.pdf) | |
| WHO recommendations and guidelines for the prevention of perinatal hepatitis B and use of hepatitis B vaccines | ||
| Steven Wiersma | ||
| Mar/2006 – Istanbul, Turkey | 288 Kb (.pdf) | |
| Hepatitis B: public health aspects – Glasgow | ||
| Syed Ahmed | ||
| Nov/2005 – Edinburgh, United Kingdom | 207 Kb (.pdf) | |
| Virology of hepatitis B | ||
| William Carman | ||
| Nov/2005 – Edinburgh, United Kingdom | 1.1 Mb (.pdf) | |
| Epidemiology and control of hepatitis A in the UK | ||
| Natasha Crowcroft | ||
| Nov/2005 – Edinburgh, United Kingdom | 329 Kb (.pdf) | |
| National hepatitis C strategy/ Action plans/ SIGN guidelines | ||
| John Dillon | ||
| Nov/2005 – Edinburgh, United Kingdom | 492 Kb (.pdf) | |
| Clinical aspects | ||
| Geoffrey Dusheiko | ||
| Nov/2005 – Edinburgh, United Kingdom | 324 Kb (.pdf) | |
| Hepatitis B: economic aspects | ||
| W. John Edmunds | ||
| Nov/2005 – Edinburgh, United Kingdom | 211 Kb (.pdf) | |
| Can the United Kingdom control viral hepatitis? Preliminary meeting conclusions. | ||
| Guido François | ||
| Nov/2005 – Edinburgh, United Kingdom | 49 Kb (.pdf) | |
| Hepatitis C: economic issues | ||
| Richard Grieve | ||
| Nov/2005 – Edinburgh, United Kingdom | 85 Kb (.pdf) | |
| Modelling transmission of HCV among intravenous drug users and in prisons | ||
| Matthew Hickman | ||
| Nov/2005 – Edinburgh, United Kingdom | 173 Kb (.pdf) | |
| Hepatitis C virus infection: monitoring of end-stage liver disease and modelling the current and future burden of disease | ||
| Sharon Hutchinson | ||
| Nov/2005 – Edinburgh, United Kingdom | 563 Kb (.pdf) | |
| Hepatitis B in London public health aspects | ||
| Helen Maguire | ||
| Nov/2005 – Edinburgh, United Kingdom | 1.1 Mb (.pdf) | |
| Epidemiology of hepatitis B in the UK | ||
| Mary Ramsay | ||
| Nov/2005 – Edinburgh, United Kingdom | 680 Kb (.pdf) | |
| Epidemiology of hepatitis C in the UK | ||
| Kristy Roy | ||
| Nov/2005 – Edinburgh, United Kingdom | 555 Kb (.pdf) | |
| The cost effectiveness of case-finding strategies for HCV infection in former injecting drug users | ||
| Ken Stein | ||
| Nov/2005 – Edinburgh, United Kingdom | 147 Kb (.pdf) | |
| How England, Wales, Scotland, and Northern Ireland fit together – politics, healthcare, decision making, research, funding | ||
| Howard Thomas | ||
| Nov/2005 – Edinburgh, United Kingdom | 129 Kb (.pdf) | |
| Management of diagnosed cases of hepatitis C virus infection | ||
| Mark Thursz | ||
| Nov/2005 – Edinburgh, United Kingdom | 533 Kb (.pdf) | |
| Transmission of blood-borne viruses in the healthcare setting | ||
| Gabriella De Carli | ||
| Mar/2005 – Rome, Italy | 589 Kb (.pdf) | |
| Current vaccination policies for healthcare workers, including booster policies, vaccination coverage, and serological testing | ||
| Antoon De Schryver | ||
| Mar/2005 – Rome, Italy | 290 Kb (.pdf) | |
| Prevalence of HBV and HCV in health care workers | ||
| Annarosa Floreani | ||
| Mar/2005 – Rome, Italy | 1.1 Mb (.pdf) | |
| Should patients be tested before undergoing invasive procedures? | ||
| Johannes Hallauer | ||
| Mar/2005 – Rome, Italy | 138 Kb (.pdf) | |
| General precautionary measures | ||
| Andreas Kopka | ||
| Mar/2005 – Rome, Italy | 1.6 Mb (.pdf) | |
| Post-exposure management of occupational exposure to blood-borne pathogens | ||
| Fortune Ncube | ||
| Mar/2005 – Rome, Italy | 494 Kb (.pdf) | |
| Risk assessement of occupational and nosocomial HBV/HCV infection by type of clinician and procedure | ||
| Lidia Proietti | ||
| Mar/2005 – Rome, Italy | 705 Kb (.pdf) | |
| Occupational fraction of HBV and HCV infections in healthcare workers globally | ||
| Annette Pruss-Ustun | ||
| Mar/2005 – Rome, Italy | 575 Kb (.pdf) | |
| Look-back (retrospective) studies | ||
| Vincenzo Puro | ||
| Mar/2005 – Rome, Italy | 367 Kb (.pdf) | |
| Definitions: exposure-prone procedures, nosocomial infection, viral-load thresholds for HBV, HCV, and HIV infectivity | ||
| Vincenzo Puro | ||
| Mar/2005 – Rome, Italy | 1.2 Mb (.pdf) | |
| Inventory of current recommendations | ||
| Kristy Roy | ||
| Mar/2005 – Rome, Italy | 469 Kb (.pdf) | |
| Feedback from the EASL study (Gunson et al., 2003) | ||
| Daniel Shouval | ||
| Mar/2005 – Rome, Italy | 397 Kb (.pdf) | |
| Quantitative HBV DNA measurements and the management of infected healthcare workers | ||
| Annemiek van der Eijk | ||
| Mar/2005 – Rome, Italy | 782 Kb (.pdf) | |
| Healthcare-related outbreaks of hepatitis B and C in the United States | ||
| Ian Williams | ||
| Mar/2005 – Rome, Italy | 468 Kb (.pdf) | |
| Co-infected healthcare workers | ||
| Yazdan Yazdanpanah | ||
| Mar/2005 – Rome, Italy | 538 Kb (.pdf) | |
| Nosocomial HCV infections in France | ||
| Anne Carbonne | ||
| Nov/2004 – Veyrier-du-Lac, France | 184 Kb (.pdf) | |
| Overview of HAV, HBV, and HCV surveillance in France | ||
| Elisabeth Delarocque-Astagneau | ||
| Nov/2004 – Veyrier-du-Lac, France | 237 Kb (.pdf) | |
| Evaluation of viral hepatitis prevention and control measures-prospects: What still needs to be done in France | ||
| Jean-Claude Desenclos | ||
| Nov/2004 – Veyrier-du-Lac, France | 98 Kb (.pdf) | |
| Prediction of HCV-related morbidity and mortality burden in France | ||
| Sylvie Deuffic-Burban | ||
| Nov/2004 – Veyrier-du-Lac, France | 194 Kb (.pdf) | |
| Presentation of the VHPB meeting conclusions | ||
| Guido François | ||
| Nov/2004 – Veyrier-du-Lac, France | 89 Kb (.pdf) | |
| HBV immunisation policies in France | ||
| Nicole Guérin | ||
| Nov/2004 – Veyrier-du-Lac, France | 159 Kb (.pdf) | |
| French regional registries (HBV and HCV, Cote d’Or and Doubs) | ||
| Patrick Hillon | ||
| Nov/2004 – Veyrier-du-Lac, France | 630 Kb (.pdf) | |
| Surveillance of adverse events following immunisation in France | ||
| Alexis Jacquet | ||
| Nov/2004 – Veyrier-du-Lac, France | 380 Kb (.pdf) | |
| French national programme for viral hepatitis prevention and control | ||
| Anne-Marie Jullien-Depradeux | ||
| Nov/2004 – Veyrier-du-Lac, France | 483 Kb (.pdf) | |
| Prevention and residual risk of HCV, HIV, and HBV infection following blood transfusion | ||
| Syria Laperche | ||
| Nov/2004 – Veyrier-du-Lac, France | 514 Kb (.pdf) | |
| Organisation, preventive health-care system, and financement in France | ||
| Martine Le Quellec-Nathan | ||
| Nov/2004 – Veyrier-du-Lac, France | 418 Kb (.pdf) | |
| Impact of hepatitis B vaccine safety issues on vaccination strategies and their implementation in France | ||
| Daniel Levy-Bruhl | ||
| Nov/2004 – Veyrier-du-Lac, France | 187 Kb (.pdf) | |
| Injecting drug users and HCV infections in France: prevention strategies and results | ||
| Damien Lucidarme | ||
| Nov/2004 – Veyrier-du-Lac, France | 493 Kb (.pdf) | |
| French national programme for viral hepatitis prevention and control: preliminary results | ||
| Patrick Marcellin | ||
| Nov/2004 – Veyrier-du-Lac, France | 139 Kb (.pdf) | |
| Epidemiology of hepatitis A and E in France | ||
| Elisabeth Nicand | ||
| Nov/2004 – Veyrier-du-Lac, France | 852 Kb (.pdf) | |
| Research on viral hepatitis in France : organisation and funding | ||
| Jean-Michel Pawlotsky | ||
| Nov/2004 – Veyrier-du-Lac, France | 676 Kb (.pdf) | |
| Epidemiology of hepatitis C in France | ||
| Francoise Roudot-Thoraval | ||
| Nov/2004 – Veyrier-du-Lac, France | 427 Kb (.pdf) | |
| Preventive measures for prisoners in France | ||
| Claire Wartelle-Bladou | ||
| Nov/2004 – Veyrier-du-Lac, France | 398 Kb (.pdf) | |
| HBV and HCV infection in health-care workers in France | ||
| Yazdan Yazdanpanah | ||
| Nov/2004 – Veyrier-du-Lac, France | 429 kb (.pdf) | |
| Epidemiology of hepatitis B in France | ||
| Fabien Zoulim | ||
| Nov/2004 – Veyrier-du-Lac, France | 530 Kb (.pdf) | |
| Vaccine supply in CEE and NIS | ||
| Katinka Aanjesen | ||
| May/2004 – Kyiv, Ukraine | 949 Kb (.pdf) | |
| Pre- and post vaccination testing and the issue of non-responders | ||
| Fransisco Averhoff | ||
| May/2004 – Kyiv, Ukraine | 153 Kb (.pdf) | |
| Introduction of a newborn hepatitis B immunisation programme in Turkey | ||
| Selim Badur, Ebru Usta | ||
| May/2004 – Kyiv, Ukraine | 280 Kb (.pdf) | |
| Current experience of hepatitis B vaccination in Italy | ||
| Paolo Bonanni | ||
| May/2004 – Kyiv, Ukraine | 328 Kb (.pdf) | |
| e-learning resource to strengthen financial planning of immunisation | ||
| Alan Brooks | ||
| May/2004 – Kyiv, Ukraine | 494 Kb (.ppt) | |
| Potential role of group procurement in the WHO European Region | ||
| Alan Brooks | ||
| May/2004 – Kyiv, Ukraine | 261 Kb (.pdf) | |
| Safety and quality of hepatitis B vaccines: Frequently asked questions in the WHO European Region | ||
| Philippe Duclos | ||
| May/2004 – Kyiv, Ukraine | 514 Kb (.pdf) | |
| Assessment of implementation of the hepatitis B prevention programme in Georgia | ||
| Lia Dzhabidze | ||
| May/2004 – Kyiv, Ukraine | 165 Kb (.pdf) | |
| Epidemiology of hepatitis B and vaccination programmes in the WHO European Region | ||
| Nedret Emiroglu | ||
| May/2004 – Kyiv, Ukraine | 2.2 Mb (.pdf) | |
| HBV, HCV, and HIV integrated programmes | ||
| Michael Favorov | ||
| May/2004 – Kyiv, Ukraine | 857 Kb (.pdf) | |
| Financial sustainability planning | ||
| Viktor Galyada | ||
| May/2004 – Kyiv, Ukraine | 173 Kb (.pdf) | |
| Overview of GAVI and the Vaccine Fund | ||
| Tore Godal | ||
| May/2004 – Kyiv, Ukraine | 1.1 Mb (.pdf) | |
| Overview of methods to evaluate the impact of hepatitis B immunisation programs | ||
| Susan Goldstein | ||
| May/2004 – Kyiv, Ukraine | 353 Kb (.pdf) | |
| Duration of protection after hepatitis B vaccination: current statut | ||
| Wolfgang Jilg | ||
| May/2004 – Kyiv, Ukraine | 194 Kb (.pdf) | |
| Blood safety in Central Asia Region | ||
| Aliya Jumagulova | ||
| May/2004 – Kyiv, Ukraine | 664 Kb (.pdf) | |
| Laboratory aspects of actute disease surveillance and the need for QA/QC | ||
| Tatiana Kalachnikova | ||
| May/2004 – Kyiv, Ukraine | 370 Kb (.pdf) | |
| Review of current recommendations regarding booster vaccination | ||
| Daniel Lavanchy | ||
| May/2004 – Kyiv, Ukraine | 202 Kb (.pdf) | |
| Strengthening immunisation systems and introduction of hepatitis B vaccine in CEE and NIS: meeting conclusions. | ||
| Alexandra Levitt | ||
| May/2004 – Kyiv, Ukraine | 144 Kb (.pdf) | |
| GAVI in the WHO European Region: results, current situation, and future | ||
| Andrei Lobanov | ||
| May/2004 – Kyiv, Ukraine | 1.3 Mb (.pdf) | |
| Burden of disease of Haemophilus influenzae type B in the WHO European Region | ||
| Andrei Lobanov | ||
| May/2004 – Kyiv, Ukraine | 724 Kb (.pdf) | |
| Injection safety of immunisation in the WHO European Region | ||
| Denis Maire | ||
| May/2004 – Kyiv, Ukraine | 1.1 Mb (.pdf) | |
| Vaccine procurement European perspectives | ||
| Denis Maire | ||
| May/2004 – Kyiv, Ukraine | 198 Kb (.pdf) | |
| Hepatitis C epidemiology in CEE and NIS countries | ||
| Harold Margolis | ||
| May/2004 – Kyiv, Ukraine | 346 Kb (.pdf) | |
| Acute viral hepatitis surveillance for hepatitis B vaccine evaluation program | ||
| Liudmila Mosin | ||
| May/2004 – Kyiv, Ukraine | 163 Kb (.ppt) | |
| Safe sharps waste collection and management in Samarkand, Uzbekistan | ||
| Irkin Musabaev | ||
| May/2004 – Kyiv, Ukraine | 1.4 Mb (.pdf) | |
| The importance of communication on immunisation safety | ||
| Dragoslav Popovic | ||
| May/2004 – Kyiv, Ukraine | 499 Kb (.pdf) | |
| Evaluation of hepatitis B prevention strategies in the Russian Federation | ||
| Marina Shevyreva | ||
| May/2004 – Kyiv, Ukraine | 257 Kb (.pdf) | |
| Implementation of financial sustainability planning in Kyrgyzstan | ||
| Ludmila Shteinke | ||
| May/2004 – Kyiv, Ukraine | 290 Kb (.pdf) | |
| Achievement with newborn and catch up hepatitis B immunisation programme in Kazakhstan | ||
| Tatiana Surdina | ||
| May/2004 – Kyiv, Ukraine | 377 Kb (.pdf) | |
| Financial sustainability planning of Uzbekistan | ||
| Dilorom Tursunova | ||
| May/2004 – Kyiv, Ukraine | 216 Kb (.pdf) | |
| Experience with sentinel surveillance in Kyrgyzstan | ||
| Rafik Usmanov | ||
| May/2004 – Kyiv, Ukraine | 379 Kb (.pdf) | |
| Birth dose: what is possible in view of other vaccines, combined vaccines, … Reflections on schedules, dosage, vaccines and interchangeability of hepatitis B vaccines | ||
| Pierre Van Damme | ||
| May/2004 – Kyiv, Ukraine | 224 Kb (.pdf) | |
| Global epidemiology and prevention of hepatitis B | ||
| Steven Wiersma | ||
| May/2004 – Kyiv, Ukraine | 717 Kb (.pdf) | |
| WHO protocol for serologic surveillance | ||
| Steven Wiersma | ||
| May/2004 – Kyiv, Ukraine | 103 Kb (.pdf) | |
| Vaccine escape mutants of HBV | ||
| Ulus Akarca | ||
| Mar/2004 – Sevilla, Spain | 2.5 Mb (.pdf) | |
| The decline of hepatitis B virus infection in the Kingdom of Saudi Arabia | ||
| Banji Ayoola | ||
| Mar/2004 – Sevilla, Spain | 489 Kb (.pdf) | |
| Are booster immunisations needed for lifelong hepatitis B immunity? | ||
| Jangu Banatvala | ||
| Mar/2004 – Sevilla, Spain | 236 Kb (.pdf) | |
| Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B | ||
| Wulf Böcher | ||
| Mar/2004 – Sevilla, Spain | 463 Kb (.pdf) | |
| Follow-up of hepatitis B vaccination: studies in Spain | ||
| Vicente Carreño | ||
| Mar/2004 – Sevilla, Spain | 990 Kb (.pdf) | |
| Follow-up of hepatitis B vaccination in Canada | ||
| Bernard Duval | ||
| Mar/2004 – Sevilla, Spain | 525 Kb (.pdf) | |
| VHPB meeting conclusions on ‘Hepatitis B vaccine: long-term efficacy, booster policy, and impact of HBV mutants on hepatitis B vaccination programmes’ | ||
| David FitzSimons | ||
| Mar/2004 – Sevilla, Spain | 138 Kb (.pdf) | |
| Are booster doses of hepatitis B vaccine necessary? Current CDC recommendations and gaps in knowledge | ||
| Susan Goldstein | ||
| Mar/2004 – Sevilla, Spain | 330 Kb (.pdf) | |
| Follow-up of hepatitis B vaccination programmes in Gambia | ||
| Andy Hall | ||
| Mar/2004 – Sevilla, Spain | 537 Kb (.pdf) | |
| Immune memory after hepatitis B vaccination | ||
| Wolfgang Jilg | ||
| Mar/2004 – Sevilla, Spain | 193 Kb (.pdf) | |
| WHO booster recommendations | ||
| Daniel Lavanchy | ||
| Mar/2004 – Sevilla, Spain | 158 Kb (.pdf) | |
| Follow-up of hepatitis B vaccination programmes in Taiwan and Singapore | ||
| Sheng-Nan Lu | ||
| Mar/2004 – Sevilla, Spain | 955 Kb (.pdf) | |
| Hepatitis B vaccine studies in Alaska | ||
| Brian McMahon | ||
| Mar/2004 – Sevilla, Spain | 732 Kb (.pdf) | |
| Evaluation of the school-based hepatitis B vaccination programme in Catalonia (Spain) | ||
| Lluis Salleras | ||
| Mar/2004 – Sevilla, Spain | 311 Kb (.pdf) | |
| Follow-up of hepatitis B vaccination: studies in Thailand | ||
| Michel Stoffel | ||
| Mar/2004 – Sevilla, Spain | 105 Kb (.pdf) | |
| Update of the universal vaccination programme in Italy | ||
| Alessandro Zanetti | ||
| Mar/2004 – Sevilla, Spain | 483 Kb (.pdf) | |
| Epidemiology of hepatitis A in Germany | ||
| Katharina Alpers | ||
| Oct/2003 – Berlin, Germany | 262 Kb (.pdf) | |
| Groups at risk for hepatitis B infection – who should be vaccinated | ||
| Ulrich Bienzle | ||
| Oct/2003 – Berlin, Germany | 121 Kb (.pdf) | |
| Hepatitis B epidemiology, surveillance, and prevention strategies in the Nordic Countries | ||
| Hans Blystad | ||
| Oct/2003 – Berlin, Germany | 146 Kb (.pdf) | |
| Hepatitis A and B outbreaks among intravenous drug users in the Nordic Countries | ||
| Hans Blystad | ||
| Oct/2003 – Berlin, Germany | 134 Kb (.pdf) | |
| Universal vaccination against hepatitis B in Germany – a paediatrician’s point of view | ||
| Uwe Busching | ||
| Oct/2003 – Berlin, Germany | 101 Kb (.pdf) | |
| Presentation of the VHPB meeting conclusions, including discussion | ||
| David Fitzsimons | ||
| Oct/2003 – Berlin, Germany | 97 Kb (.pdf) | |
| Molecular epidemiology of HBV mutants | ||
| Wolfram Gerlich | ||
| Oct/2003 – Berlin, Germany | 2.2 Mb (.pdf) | |
| Organisation of the health care system in Germany | ||
| Johannes Hallauer | ||
| Oct/2003 – Berlin, Germany | 416 Kb (.pdf) | |
| Screening pregnant women for hepatitis B: results from two studies | ||
| Wolfgang Jilg | ||
| Oct/2003 – Berlin, Germany | 88 Kb (.pdf) | |
| Development of hepatitis B prevention in Germany – the first 10 years | ||
| Wolfgang Jilg | ||
| Oct/2003 – Berlin, Germany | 82 Kb (.pdf) | |
| Critical review of programme progress | ||
| Michael Kramer, Johannes Hallauer | ||
| Oct/2003 – Berlin, Germany | 62 Kb (.pdf) | |
| Federal law on communicable diseases (Infektionsschutzgesetz) – Reporting systems | ||
| Michael Kramer | ||
| Oct/2003 – Berlin, Germany | 258 Kb (.pdf) | |
| Evaluation of a hepatitis B selective vaccination programme in Norway | ||
| Hanne Nokleby | ||
| Oct/2003 – Berlin, Germany | 78 Kb (.pdf) | |
| School-entry monitoring of vaccination status | ||
| Gunter Pfaff | ||
| Oct/2003 – Berlin, Germany | 399 Kb (.pdf) | |
| Epidemiology of hepatitis B in Germany | ||
| Doris Radun | ||
| Oct/2003 – Berlin, Germany | 244 Kb (.pdf) | |
| Epidemiology of hepatitis A in Sweden – the same old story? | ||
| Lars Rombo | ||
| Oct/2003 – Berlin, Germany | 298 Kb (.pdf) | |
| Investigation of a cluster of nosocomial HBV infections in Sweden – obstacles and efforts | ||
| Johan Struwe | ||
| Oct/2003 – Berlin, Germany | 331 Kb (.pdf) | |
| Problems associated with the introduction of HBsAg-positive children in day care centres | ||
| Johan Struwe | ||
| Oct/2003 – Berlin, Germany | 72 Kb (.pdf) | |
| Countering the anti-vaccination movement and vaccination scares – Working with the media | ||
| Robert Aston | ||
| Mar/2003 – Geneva, Switzerland | 4.3 Mb (.ppt) | |
| Communication: The role of the industry | ||
| Hugues Bogaerts, Luc Hessel | ||
| Mar/2003 – Geneva, Switzerland | 61 Kb (.ppt) | |
| The Brighton Collaboration: comparability of vaccine safety data | ||
| Jan Bonhoeffer | ||
| Mar/2003 – Geneva, Switzerland | 419 Kb (.ppt) | |
| Impact of safety issues in Scotland | ||
| Claire Bramley | ||
| Mar/2003 – Geneva, Switzerland | 1.4 Mb (.ppt) | |
| The global advisory committee on Vaccine Safety (GACVS) and its communication strategy | ||
| Philippe Duclos | ||
| Mar/2003 – Geneva, Switzerland | 214 Kb (.ppt) | |
| Impact of safety issues in France | ||
| Nicole Guérin | ||
| Mar/2003 – Geneva, Switzerland | 87 Kb (.ppt) | |
| Impact of safety issues in Germany | ||
| Johannes Hallauer | ||
| Mar/2003 – Geneva, Switzerland | 644 Kb (.ppt) | |
| International impact of vaccine safety concerns | ||
| Mark Kane | ||
| Mar/2003 – Geneva, Switzerland | 33 Kb (.ppt) | |
| New communication issues around immunisation | ||
| Heidi Larson | ||
| Mar/2003 – Geneva, Switzerland | 1.1 Mb (.ppt) | |
| Thiomersal-related changes in vaccination recommendations and hepatitis B vaccine coverage among United States children | ||
| Harold Margolis | ||
| Mar/2003 – Geneva, Switzerland | 350 Kb (.ppt) | |
| Infant hepatitis B vaccination and childhood leukaemia | ||
| Harold Margolis | ||
| Mar/2003 – Geneva, Switzerland | 87 Kb (.ppt) | |
| Impact of litigation issues on hepatitis B vaccination | ||
| Robert Pless | ||
| Mar/2003 – Geneva, Switzerland | 2.5 Mb (.pdf) | |
| Impact of safety issues in Israel | ||
| Daniel Shouval | ||
| Mar/2003 – Geneva, Switzerland | 96 Kb (.ppt) | |
| The Immunization Action Coalition (IAC) | ||
| Deborah L. Wexler | ||
| Mar/2003 – Geneva, Switzerland | 2.4 Mb (.ppt) | |
| The Viral Hepatitis Prevention Board, 10 years of support to the control and prevention of viral hepatitis in Europe. | ||
| Alex Vorsters | ||
| Jan/2003 – San Antonio, Texas, USA | 652 Kb (.ppt) | |
| Molecular tracing of HCV: options for control of hospital transmission | ||
| Filippo Ansaldi | ||
| Nov/2002 – Catania, Italy | 177 Kb (.ppt) | |
| Prevention of hepatitis A during outbreaks and post exposure | ||
| Paolo Bonanni | ||
| Nov/2002 – Catania, Italy | 275 Kb (.ppt) | |
| Epidemiology of hepatitis B core/pre-core mutants in Italy | ||
| Maurizia Brunetto | ||
| Nov/2002 – Catania, Italy | 1.4 Mb (.ppt) | |
| Epidemiology of hepatitis A and E in Italy | ||
| Rosa Cristina Coppola | ||
| Nov/2002 – Catania, Italy | 1.9 Mb (.ppt) | |
| Epidemiology of hepatitis B and C in Italy from the eighties until now | ||
| Pietro Crovari | ||
| Nov/2002 – Catania, Italy | 272 Kb (.ppt) | |
| Update on WHO GAVI European Regional Working Group and hepatitis B immunization | ||
| Nedret Emiroglu | ||
| Nov/2002 – Catania, Italy | 970 Kb (.ppt) | |
| Presentation of the VHPB meeting conclusions | ||
| David FitzSimons | ||
| Nov/2002 – Catania, Italy | 50 Kb (.ppt) | |
| The new Italian guidelines for the use of hepatitis A vaccine | ||
| Elisabetta Franco | ||
| Nov/2002 – Catania, Italy | 121 Kb (.ppt) | |
| The hepatitis A epidemic in Puglia, Italy: lessons learnt and application of prevention programmes | ||
| Pier Luigi Lopalco | ||
| Nov/2002 – Catania, Italy | 1.3 Mb (.ppt) | |
| Integrated epidemiological system for acute viral hepatitis (SEIEVA) | ||
| Alfonso Mele | ||
| Nov/2002 – Catania, Italy | 599 Kb (.ppt) | |
| Organisation of the health care system in Italy | ||
| Maria Grazia Pompa | ||
| Nov/2002 – Catania, Italy | 230 Kb (.ppt) | |
| Programme of HBV vaccination targeted to risk groups – Long-term protection after hepatitis B vaccination in a cohort of exposed newborns | ||
| Tommaso Stroffolini | ||
| Nov/2002 – catania, Italy | 49 Kb (.ppt) | |
| Evaluation framework of viral hepatitis prevention programmes: examples in Italy – Impact of ten years of universal hepatitis B vaccination programmes | ||
| Tommaso Stroffolini | ||
| Nov/2002 – Catania, Italy | 99 Kb (.ppt) | |
| Prevention of hepatitis C and residual risk of HCV, HIV, and HBV infection following blood transfusion: results of an Italian study | ||
| Alessandro Zanetti | ||
| Nov/2002 – Catania, Italy | 82 Kb (.ppt) | |
| Hepatitis E in Italy | ||
| Alessandro Zanetti | ||
| Nov/2002 – Catania, Italy | 158 Kb (.ppt) | |
| Epidemiology of hepatitis B surface antigen mutants in Italy: role and consequences for vaccination programmes | ||
| Alessandro Zanetti | ||
| Nov/2002 – Catania, Italy | 779 Kb (.ppt) | |
| How to collect and evaluate surveillance and epidemiologic data for hepatitis C | ||
| Miriam Alter | ||
| May/2002 – Geneva, Switzerland | 499 Kb (.ppt) | |
| Hepatitis C infection in Turkey | ||
| Selim Badur | ||
| May/2002 – Geneva, Switzerland | 393 Kb (.ppt) | |
| Surveillance of hepatitis C infection in France | ||
| Jean-Claude Desenclos | ||
| May/2002 – Geneva, Switzerland | 211 Kb (.ppt) | |
| The hepatitis C virus | ||
| Peter Grob | ||
| May/2002 – Geneva, Switzerland | 942 Kb (.pdf) | |
| Estimating the global burden of HCV infections associated with unsafe health care injections | ||
| Yvan Hutin | ||
| May/2002 – Geneva, Switzerland | 408 Kb (.ppt) | |
| Natural history of HCV infection | ||
| Daniel Lavanchy | ||
| May/2002 – Geneva, Switzerland | 1.1 Mb (.pdf) | |
| Global epidemiology of HCV infection | ||
| Daniel Lavanchy | ||
| May/2002 – Geneva, Switzerland | 1 Mb (.pdf) | |
| Human immune response to hepatitis C virus | ||
| Geert Leroux-Roels | ||
| May/2002 – Geneva, Switzerland | 893 Kb (.ppt) | |
| Hepatitis C: therapeutic options | ||
| Michael Manns | ||
| May/2002 – Geneva, Switzerland | 1.8 Mb (.ppt) | |
| Prevention of hepatitis C virus infection: achievement through integration into established prevention programmes | ||
| Harold Margolis | ||
| May/2002 – Geneva, Switzerland | 360 Kb (.ppt) | |
| Epidemiology, prevention, and control programmes of hepatitis C in Egypt | ||
| Mostafa Mohamed | ||
| May/2002 – Geneva, Switzerland | 901 Kb (.ppt) | |
| Tackling the HCV epidemic in Switzerland | ||
| Francesco Negro | ||
| May/2002 – Geneva, Switzerland | 336 Kb (.ppt) | |
| Integrating prevention, control, and therapy for viral hepatitis: the Canadian model | ||
| David Patrick | ||
| May/2002 – Geneva, Switzerland | 1.3 Mb (.ppt) | |
| Laboratory and clinical diagnosis of HCV infection | ||
| Jean-Michel Pawlotsky | ||
| May/2002 – Geneva, Switzerland | 210 Kb (.pdf) | |
| Clinical manifestations of HCV infection | ||
| Daniel Shouval | ||
| May/2002 – Geneva, Switzerland | 396 Kb (.ppt) | |
| Health strategy on HCV in The Netherlands | ||
| Jan Van Hattum | ||
| May/2002 – Geneva, Switzerland | 423 Kb (.ppt) | |
| HCV injecting drug users: developing indicators of prevalence and responses | ||
| Lucas Wiessing | ||
| May/2002 – Geneva, Switzerland | 1.3 Mb (.ppt) | |
| Public health challenges for controlling HCV infection | ||
| Alessandro Zanetti | ||
| May/2002 – Geneva, Switzerland | 107 Kb (.ppt) | |
| Evaluation framework of viral hepatitis prevention programmes: examples in Italy – Impact of ten years of universal hepatitis B vaccination programmes | ||
| Paolo Bonanni | ||
| Jan/2002 – Catania, Italy | 418 Kb (.ppt) | |
| Combined paediatric vaccines for national immunisation programmes. | ||
| Francis André | ||
| Oct/2001 – St. Julians, Malta | 1.6 Mb (.ppt) | |
| Economic aspects of combined vaccines. | ||
| Philippe Beutels | ||
| Oct/2001 – St. Julians, Malta | 59 Kb (.ppt) | |
| Combined vaccines with a hepatitis B component – The role of non-clinical testing in ensuring their safety and efficacy. | ||
| Roland Dobbelaer | ||
| Oct/2001 – St. Julians, Malta | 360 Kb (.ppt) | |
| Presentation of the VHPB conclusions. | ||
| David FitzSimons | ||
| Oct/2001 – St. Julians, Malta | 46 Kb (.ppt) | |
| Infant and adolescent vaccination schedules in Europe | ||
| Nicole Guérin | ||
| Oct/2001 – St. Julians, Malta | 86 Kb (.ppt) | |
| Decision-making process and impact of implementation of hexavalent vaccines in national immunisation programmes: the case of Germany. | ||
| Wolfgang Jilg | ||
| Oct/2001 – St. Julians, Malta | 62 kb (.ppt) | |
| Immunogenicity profile of combined vaccines in infants. | ||
| Helena Kayhty | ||
| Oct/2001 – St. Julians, Malta | 508 Kb (.ppt) | |
| Hepatitis B vaccination: an alternative (re)view. | ||
| Geert Leroux-Roels | ||
| Oct/2001 – St. Julians, Malta | 984 Kb (.ppt) | |
| New vaccine supply and financing: a case study of combination vaccines in developing countries. | ||
| Susan McKinney | ||
| Oct/2001 – St. Julians, Malta | 417 Kb (.ppt) | |
| Overview of the vaccination programme in Malta. | ||
| Mark Muscat | ||
| Oct/2001 – St. Julians, Malta | 125 Kb (.ppt) | |
| European regulatory authorities’ perspective and view on proving safety and immunogenicity of combined vaccines – General aspects – Recent experiences. | ||
| Michael Pfleiderer | ||
| Oct/2001 – St. Julians, Malta | 61 Kb (.ppt) | |
| Infant and adolescent hepatitis B vaccination and use of combination vaccines – USA. | ||
| Fred Shaw | ||
| Oct/2001 – St. Julians, Malta | 229 Kb (.ppt) | |
| HEXAVAC – A new liquid DTacP-IPV-Hib-HB hexavalent vaccine – Overview of its clinical profile. | ||
| Benoit Soubeyrand | ||
| Oct/2001 – St. Julians, Malta | 286 Kb (.ppt) | |
| Importance of combined hepatitis B vaccines – Point of view of a paediatrician | ||
| Vytautas Usonis | ||
| Oct/2001 – St. Julians, Malta | 187 Kb (.ppt) | |
| Countries in Europe where combined vaccines are licensed. | ||
| Pierre Van Damme | ||
| Oct/2001 – St. Julians, Malta | 27 Kb (.ppt) | |
| Lessons learned from Turkey | ||
| Selim Badur | ||
| Jun/2001 – St. Petersburg, Russia | 235 Kb (.ppt) | |
| Financing Multi-Year Plans | ||
| Alan Brooks | ||
| Jun/2001 – St. Petersburg, Russia | 108 Kb (.ppt) | |
| Vaccine Fund | ||
| Alan Brooks | ||
| Jun/2001 – St. Petersburg, Russia | 295 Kb (.ppt) | |
| Hepatitis B vaccines: safety and side-effect profile. | ||
| Philippe Duclos | ||
| Jun/2001 – St. Petersburg, Russia | 171 Kb (.ppt) | |
| In Country Coordination | ||
| Nedret Emiroglu | ||
| Jun/2001 – St. Petersburg, Russia | 177 Kb (.ppt) | |
| Review of the hepatitis B vaccination programmes and the progress made since Siofok, 1996 in CEE and NIS countries. | ||
| Nedret Emiroglu | ||
| Jun/2001 – St. Petersburg, Russia | 526 Kb (.ppt) | |
| Overview of the hepatitis B, C and D epidemiology in CEE and NIS countries | ||
| Michael Favorov | ||
| Jun/2001 – St. Petersburg, Russia | 132 Kb (.ppt) | |
| Outcome evaluation and impact assessment. | ||
| Susan Goldstein | ||
| Jun/2001 – St. Petersburg, Russia | 447 Kb (.ppt) | |
| Hepatitis B vaccines: quality, immunogenicity. | ||
| Susan Goldstein | ||
| Jun/2001 – St. Petersburg, Russia | 144 Kb (.ppt) | |
| Details on long-term immunogenicity and Booster policy | ||
| Susan Goldstein | ||
| Jun/2001 – St. Petersburg, Russia | 90 Kb (.ppt) | |
| Outcome evaluation of an universal hepatitis B immuniszation programme | ||
| Johannes Hallauer | ||
| Jun/2001 – St. Petersburg, Russia | 140 Kb (.ppt) | |
| Hepatitis B vaccines: Quality issues, dosages, schedules | ||
| Wolfgang Jilg | ||
| Jun/2001 – St. Petersburg, Russia | 97 Kb (.ppt) | |
| Infectious Diseases Laboratory Quality Control – Essential Component for Public Health Improvement | ||
| Tatiana Kalachnikova | ||
| Jun/2001 – St. Petersburg, Russia | 540 Kb (.ppt) | |
| Overview of GAVI and the Global Fund for Children’s Vaccines | ||
| Mark Kane | ||
| Jun/2001 – St. Petersburg, Russia | 729 Kb (.ppt) | |
| GAVI Regional Working Group & Status of GAVI Implementation | ||
| Denis Maire | ||
| Jun/2001 – St. Petersburg, Russia | 157 Kb (.ppt) | |
| Hepatitis B prevention strategies in the broader context of hepatitis B and C prevention. | ||
| Harold Margolis | ||
| Jun/2001 – St. Petersburg, Russia | 584 Kb (.ppt) | |
| Global epidemiology of hepatitis B and review of prevention strategies in the world. | ||
| Eric Mast | ||
| Jun/2001 – St. Petersburg, Russia | 722 Kb (.ppt) | |
| Health Information Systems | ||
| Ljudmyla Muharska, Galina Shevschenko | ||
| Jun/2001 – St. Petersburg, Russia | 463 Kb (.ppt) | |
| Health Information Systems | ||
| Ljudmyla Muharska, Galina Shevschenko | ||
| Jun/2001 – St. Petersburg, Russia | 504 Kb (.ppt) | |
| Quality Control Systems for hepatitis B and C diagnostics in Uzbekistan. | ||
| Irkin Musabaev | ||
| Jun/2001 – St. Petersburg, Russia | 337 Kb (.ppt) | |
| Introduction of New Vaccines (example of Hib). | ||
| Pem Namgyal | ||
| Jun/2001 – St. Petersburg, Russia | 136 Kb (.ppt) | |